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  Abstract 
 
 
Abstract 
 
Collagen II is the major collagen present in the extracellular matrix of cartilage, in addition it is 
found in the vitreous of the eye and it is also detected during early embryogenesis. Due to the 
complexity of the biosynthesis, assembly and secretion, collagen II is highly susceptible to 
mutations leading to disease states which are broadly classified as chondrodysplasias. Most of 
these mutations are substitutions of glycine in the Gly-X-Y repeats in the triple helical domain 
resulting in destabilization of the helix. Point mutations leading to arginine to cysteine 
substitution are interesting since they occur at either X or Y position and cause two different 
diseases termed Stickler syndrome and congenital spondyloepiphyseal dysplasia (SEDC) in 
association with osteoarthritis.  
The present study aimed at determining the consequences of arginine to cysteine substitutions in 
either X or the Y position in the Gly-X-Y repeats and at either the N- or the C- terminus of the 
triple helix. The impact of these mutations on protein trafficking, secretion and cell survival was 
also analyzed. 
Biochemical studies revealed great similarities between R75C, R134C and R704C collagens and 
the wild type molecules with the exception that electron micrographs of R75C collagen 
displayed kinks in the structure. R740C and R789C collagens accumulated in the cells and the 
R789C protein migrated faster on SDS gels. The R740C and R789C proteins were also 
susceptible to protease digestion and circular dichroism spectra were altered and showed lower 
Tm values than other collagen II variants. Due to the altered structure, R789C protein was more 
susceptible to MMP cleavage in the vicinity of the mutation causing the truncation of the protein. 
Additionally, electron micrographs revealed only scarce and thin filamentous structures in 
preparations of R740C and R789C protein. The biochemical results indicate that the R740C and 
R789C proteins have unstable triple helices and that this affects the overall protein structure. 
Protein trafficking was monitored in HT1080 cells expressing the collagen II variants. 
Intracellular retention in the ER due to misfolding of the R740C and R789C proteins triggered an 
ER stress response including splicing of XBP-1 and induction and binding of BiP. Continuous 
accumulation of misfolded proteins in the ER caused apoptosis of the R740C and R789C 
expressing cells. 
Substitution of arginine to cysteine in the X or Y position towards the C-terminus of the triple 
helix caused pronounced instability of the triple helix with a deleterious effect on the cells, while 
R704C and more N-terminal mutations did not cause any significant changes irrespective of 
being in the X or the Y position. 
The different severities of patient phenotypes are due to a combination of structural factors, 
which may be synergistically augmented by genetic modifiers, additional unknown mutations 
and environmental factors.    
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Zusammenfassung 
 
Collagen II ist der Hauptbestandteil der extrazellulären Matrix des Knorpels. Außerdem wird 
Collagen II im Glaskörper des Auges exprimiert und konnte während der frühen embryonalen 
Entwicklung nachgewiesen werden. Collagen II ist durch seine komplexe Biosynthese, 
Assemblierung und Sekretion besonders anfällig für Mutationen, die im Menschen zu 
Krankheiten führen, die allgemein unter dem Begriff Chondrodysplasien zusammengefasst 
werden. Bei den meisten dieser Mutationen handelt es sich um den Austausch eines Glycins in 
den Gly-X-Y Triplets der tripelhelikalen Domäne, die zu einer Destabilisierung dieser Helix 
führen. Punktmutationen, die zu einem Austausch von Arginin zu Cystein führen, kommen 
sowohl in der X- als auch Y-Position vor und führen interessanterweise zu zwei 
unterschiedlichen Krankheitsbildern, dem Stickler Syndrom bzw. der congenitalen 
Spondyloepiphysiären Dysplasie verbunden mit Osteoarthrose. 
In der vorliegenden Arbeit wurden Auswirkungen von Substitutionen eines Arginins zu einem 
Cystein sowohl in der X- als auch in der Y-Position bzw. im N- oder C-terminalen Bereich der 
Tripelhelix untersucht. Außerdem wurden Effekte dieser Mutationen auf den intrazellulären 
Proteintransport, die Sekretion und die Zellvitalität analysiert. 
Biochemische Untersuchungen ergaben keinerlei wesentliche Unterschiede zwischen den 
Mutanten R75C, R134C und R704C im Vergleich mit dem Wildtyp Protein mit Ausnahme der 
elektronenmikroskopischen Aufnahmen, in denen die Mutation R75C zu charakteristischen 
Knicken in der Struktur des Collagens führte. Die Proteine R740C und R789C akkumulierten 
intrazellulär, und das Collagen R789C zeigte veränderte Laufeigenschaften im SDS Gel. Die 
Proteine R740C und R789C waren außerdem empfindlicher gegenüber Proteasen, und die 
Analyse mittels CD Spektroskopie ergab untypische Spektren und erniedrigte 
Schmelztemperaturen. Die durch die veränderte Struktur erhöhte Empfindlichkeit des Proteins 
R789C gegenüber dem Abbau durch MMPs in unmittelbarer Nähe der Mutation führte zu einer 
Verkürzung des Proteins durch Proteolyse. 
In elektronenmikroskopischen Untersuchungen der Proteine R740C und R789C konnten nur 
kurze filamentöse Strukturen nachgewiesen werden. Diese Ergebnisse führen zu dem Schluss, 
dass die Proteine R740C und R789C lediglich instabile Tripelhelices ausbilden und die 
Mutationen so die Gesamtstruktur des Proteins beeinflussen. 
Der intrazelluläre Transport der mutierten Proteine wurde in transfizierten HT1080 Zellen 
untersucht. Die fehlgefalteten Proteine R740C und R789C wurden im endoplasmatischen 
Retikulum (ER) zurückgehalten und lösten eine ER Stressantwort aus, die mit einem Splicing 
von XBP-1 und einer erhöhten Induktion und Bindung des Chaperons BiP einhergeht. Die 
andauernde Akkumulation dieser fehlgefalteten Proteine im ER führte schließlich zur Auslösung 
der Apopotse. 
Der Austausch von Arginin zu Cystein im C-terminalen Bereich der Tripelhelix führte sowohl in 
der X- als auch der Y-Position zur Instabilität der Tripelhelix mit schädlichen Auswirkungen auf 
die exprimierenden Zellen. Im Gegensatz hierzu resultierten bereits die Mutation R704C und 
weiter N-terminal gelegene Mutationen in keinerlei signifikanten Veränderungen, unabhängig 
davon, ob sie in der X- bzw. Y-Position vorlagen. 
Die in Patienten beschriebenen, sehr unterschiedlich ausgeprägten Krankheitsbilder sind 
wahrscheinlich durch eine Kombination sich synergistisch verstärkender struktureller und 
genetischer Faktoren sowie unbekannter Mutationen und Umwelteinflüsse zu erklären. 
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1 Introduction 
1.1 Collagen 
Collagens form a family of proteins that constitute the major structural components of the ECM, 
representing approximately one third of the body protein in man. The general definition of a 
collagen is “a protein consisting of three identical or related polypeptide chains, which are folded 
into at least one triple-helical domain and assemble into supramolecular aggregates mostly in the 
extracellular space”. They are found in almost all tissues of the body, and are particular abundant 
in bone, skin, tendon, ligaments, cartilage and vessel walls (Myllyharju & Kivirikko 2004). 
1.2 Classification of collagens 
Collagens are characterized by the presence of triple-helical domains, which are either composed 
of three identical polypeptide chains (homotrimers) or two to three genetically distinct chains 
(heterotrimers). The collagen types are designated with Roman numerals in the order of their 
discovery, and the chains found in each collagen type are identified with Arabic numerals 
(Kivirikko 1993, Pihlajaniemi & Rehn 1995, Prockop & Kivirikko 1995, Myllyharju & 
Kivirikko 2004). Collagens are broadly classified into two groups on the basis of their primary 
structure, physicochemical properties and macromolecular assembly: 
1. Fibrillar collagens (over 70% of total collagens; e.g. type I, II, III, V, XI), possessing a large, 
uninterrupted triple-helical domain capable of fibril formation. Their fibrils create the 
structural frameworks for many tissues. 
2. The non-fibril-forming collagens, made up by basement membrane collagens (type IV and 
VII), transmembrane collagens (type XIII and XVII), fibril-associated collagens with 
interrupted triple helices (FACIT; type IX, XII, XIV, XVI and XIX), multiplexin collagens 
(type XV and XVIII), short-chain collagens (type VI, VIII and X) form a more 
heterogeneous group. A distinct feature of non-fibril-forming collagens is the presence of one 
or more non collagenous interruptions within the collagenous sequence. Members of this 
group form filaments, sheet-like structures, network-like elements and anchoring fibrils and 
can associate with collagen fibrils and membranes in a highly tissue-specific manner in 
variety of organs. 
Fig 1.1 summarizes the classification within the collagen superfamily, the known collagen 
supramolecular assemblies and molecular and functional properties.  
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Fig 1.1 Members of the collagen superfamily and their known supramolecular assemblies. The collagen 
superfamily can be divided into nine families on the basis of the supramolecular assemblies and other features of its 
members: (a) fibril-forming collagens; (b) fibril-associated collagens with interrupted triple helices (FACITs), 
located at the surface of fibrils, and structurally related collagens; (c) collagens forming hexagonal networks; (d) the 
family of type IV collagens located in basement membranes; (e) type VI collagen, which forms beaded filaments; (f) 
type VII collagen, which forms anchoring fibrils at basement membranes; (g) collagens with transmembrane 
domains; and (h) the family of type XV and XVIII collagens. The supramolecular assemblies of families (g) and (h) 
are unknown and are therefore not shown (Myllyharju & Kivirikko 2004). 
 
1.3 Genes and nomenclature 
The genes encoding the fibril-forming collagens I-III show structural similarity but vary in size 
from 18 to 44 kb (Prockop & Kivirikko 1995, Yamada et al. 1980). They consist of 51-54 exons 
with the major triple-helical domain being encoded by 44 exons. The similarity in gene structure 
is also extended to propeptides. The N-propeptide is in each case encoded by six exons, whereas 
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the C-propeptides are encoded by four exons. The gene loci for the members of the collagen 
family have been given names beginning with COL in a human context and col in animals, 
followed by an Arabic numeral denoting the collagen. For example, COL1A1 is the gene locus 
for the human proα1(I) chain, and COL1A2 for the proα2(I) chain. 
All the exons encoding the triple-helical domain are of sizes that are multiples of 9 bp (e.g. 45, 
54, 99, 108 and 162 bp, coding for 5, 6, 11, 12 and 18 Gly-X-Y triplets, respectively), the most 
common size being 54 bp. It has been suggested that the ancestral gene for the fibril-forming 
collagens must have evolved by amplification of a 54 bp unit embedded into intron sequences 
(Yamada et al. 1980). All these exons start with a codon for glycine and end with a complete 
codon for an amino acid in the Y position. 
1.4 Structure and stability of the collagen triple helix 
In collagens three α chains are wound around each other into a right-handed triple helix. In some 
collagens all three chains in the molecule are identical and form homotrimers, while other types 
contain two or even three different chains leading to heterotrimeric molecules (Engel & Prockop 
1991, Hulmes 1992).  At the amino acid level the collagenous or triple helical domains contain 
of repeats consisting of three amino acids (Fig 1.2A). The presence of glycine as every third 
amino acid in the repeating Gly-X-Y sequence is essential because a larger amino acid would not 
fit in the center of the triple helix where the three chains come together (Fig 1.2B). Proline is 
frequently in the X position of the Gly-X-Y sequence and 4-hydroxyproline is frequently in the 
Y position. These two amino acids limit the rotation of the polypeptide chains. The triple helix is 
further stabilized by hydrogen bonds and water bridges, many of which require the presence of 
4-hydroxyproline. Stabilization of the triple helix by glycines has been studied using collagen-
like peptides (Bella et al. 1994, 1995). In addition, many glycine substitutions in the collagen 
triple helix have been identified in various heritable connective tissue disorders (Kivirikko 1993, 
Dalgleish 1997, 1998). These glycine substitutions result in a small local untwisting of the triple 
helix and reduce its thermal stability (Bella et al. 1994), suggesting that similar conformational 
changes may occur in the case of glycine substitutions at other positions. It is also thought that 
glycine substitutions may reduce the rate of folding of the triple helix, as a Gly to Cys 
substitution within the collagen domain of type I collagen prolongs the time needed to reach the 
triple-helical state (Raghunath et al. 1994). 
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Fig 1.2 Arrangement of amino acids in the Gly-X-Y repeat in the triple helical part of a fibrillar collagen. (A) 
Characteristic Gly-X-Y repeat with the orientation of glycine. (B) The central fit of glycine in the structure of triple 
helix with all other amino acid being more peripheral (Cooper & Hausman 2004, Nelson & Cox 2005). 
 
1.5 Biosynthesis of collagen 
Collagen biosynthesis and assembly follows the normal pathway of a secretory protein. Fig 1.3 
represents a schematic illustration of the intracellular and extracellular events during collagen 
biosynthesis, which are briefly described below. 
1. Synthesis: Collagen chains are synthesized as longer precursors called procollagens. The 
growing polypeptide chains are co-translationally transported into the lumen of the rough 
endoplasmic reticulum (ER). In the ER, the procollagen chain undergoes a series of post-
translational modifications, in particular hydroxylation and glycosylation.  
2. Hydroxylation: Specific proline and lysine residues in the propeptide are hydroxylated by 
membrane-bound hydroxylases. These hydroxyproline residues are essential for the stability of 
triple helical molecules since underhydroxylated procollagens are not stable at normal body 
A 
B 
  Introduction 
 5
temperature. Lysyl hydroxylase and proline hydroxylase catalyses the hydroxylation of lysine 
and proline residues in the procollagen chains. The hydroxylysine residues serve as attachment 
sites for carbohydrate units and are also needed for the formation of intermolecular cross-links 
during the collagen fibril formation. Ascorbate is a cofactor required for hydroxylase activity and 
a deficiency may lead to triple helix instability. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.3 Intracellular and extracellular events during collagen biosynthesis and fibrillogenesis.  (A) Procollagen 
synthesis, posttranslational modification, secretion and fibril assembly. (B) Electron micrograph of a negatively 
stained collagen fibril reveals its typical striated appearance (Alberts et al. 1994). 
 
 
3. Glycosylation: Procollagens are further glycosylated in the ER and in the Golgi complex. 
Galactose and glucose residues are added to hydroxylysine residues and longer oligosaccharides 
are transferred to certain asparagine residues in the C-terminal propeptide. 
4. Procollagen assembly: N- and C-propeptides first fold and intrachain disulphide bonds are 
formed within them (Bächinger et al. 1981, Doege & Fessler 1986). Three pro α chains then 
associate through non-covalent interactions between the folded C-propeptides followed by 
formation of interchain disulphide bonds catalyzed by protein disulphide isomerase (PDI) (Olsen 
et al. 1976, Forster & Freedman 1984, Noiva & Lennarz 1992). The formation of a triple-helical 
procollagen molecule begins by association of the C-propeptides of the three pro α chains 
B
A 
B 
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(Bächinger et al. 1981, Bulleid et al. 1996) and the triple helix is formed in a zipper-like manner 
proceeding from the C-terminal region towards the N-terminus (Engel & Prockop 1991).  
5. Quality control: During the entire process molecular chaperones play an important role in 
regulating the correct folding and assembly of proteins (Fig 1.4). Chaperones bind to 
hydrophobic regions of unfolded proteins and prevent aggregation while the polypeptides are 
synthesized (Gething & Sambrook 1992, Becker & Craig 1994, Hartl et al. 1994). They also 
serve as folding quality controllers, preventing the secretion of misfolded proteins and promoting 
their degradation. BiP is a 78 kD protein located within the lumen of the ER and plays a general 
role in protein folding and oligomeric assembly (Haas & Wabl 1983). In certain osteogenesis 
imperfecta patients, mutant type I collagen remains bound to BiP (Chessler & Byers 1992). PDI 
also acts as a molecular chaperone during the assembly of procollagen chains (Wilson et al. 
1998). PDI interacts specifically with the propeptides of monomeric type I procollagen chains 
and prevents their premature assembly or aggregation (Wilson et al. 1998). 
 
 
Fig 1.4 Interactions of ER chaperones during procollagen assembly and secretion. Procollagen interacts with a 
variety of ER resident proteins during folding and assembly within the ER. The carboxy-terminal propeptide may 
interact transiently with BiP (light blue) before it folds correctly and assembles covalently with two other pro-α-
chains to form a trimer. Protein disulfide isomerase (PDI; blue) catalyzes this latter event. Proline hydroxylases 
(P4H; green) modifies selected proline and lysine residues in the triple helix-forming domains. These hydroxylated 
residues form hydrogen bonds that stabilize the helix once it forms. This triple helical form of procollagen is the 
preferred substrate of Hsp47 (yellow) (Hendershot & Bulleid 2000). 
 
Hsp47 is an endoplasmic reticulum (ER)-resident molecular chaperone that is specific for 
collagen and plays a role in collagen maturation (Nagata & Hosokawa 1996, Nagata 2003). After 
binding to procollagen in the ER, Hsp47 is co-transported with procollagen from the ER to the 
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cis-Golgi or ER-Golgi intermediate compartment, where it dissociates from procollagen in a pH-
dependent manner (Saga et al. 1987, Satoh et al. 1996). 
6. Secretion: The mechanism responsible for transporting assembled procollagen molecules 
from the ER to the Golgi complex is poorly understood. Various studies have shown that triple-
helical procollagen molecules form large electron-dense aggregates in a cis-Golgi compartment 
of fibroblasts and that these aggregates then move across the Golgi stacks without leaving the 
lumen of the Golgi cisternae (Bonfanti et al. 1998). Progressive maturation of the Golgi cisternae 
appears to be responsible for the transport through the Golgi complex (Mironov et al. 1997). If 
triple helix formation is prevented and random coil polypeptide chains accumulate within the 
cisternae of the rough endoplasmic reticulum, they are degraded in part or secreted at a delayed 
rate (Kivirikko et al. 1992). Detailed investigations using video-electron microscopy, serial-
section 3D reconstruction and electron tomography have shown that procollagens are transported 
in saccular structures formed directly from protruding portions of the ER membrane (Mironov et 
al. 2003). 
7. Procollagen processing: In the extracellular space the N- and C-propeptides of procollagens 
are cleaved by specific proteinases before the molecules start to self-assemble into fibrils 
(Prockop & Hulmes 1994, Canty & Kadler 2005) (Fig 1.5). These procollagen proteinases are 
endopeptidases and require a divalent cation such as Ca2+ for maximal activity (Hojima et al. 
1989, Prockop et al. 1998). Propeptides are cleaved by two enzymes, procollagen N proteinase 
and procollagen C proteinase, which cleave N- and C-propeptides respectively (Prockop et al. 
1998, Kivirikko 1995) Procollagen C proteinase activity (Hojima et al. 1985) is exerted by 
members of the tolloid family of zinc metalloproteinases [bone morphogenetic protein 1 (BMP-
1), mammalian tolloid (mTLD) and tolloid like 1 (TLL-1); (Hartigan et al. 2003, Kessler et al. 
1996, Li et al. 1996, Scott et al. 1999)] and N-proteinase activity is provided by members of the 
ADAMTS (metalloproteinase with thrombospondin motifs) family: ADAMTS-2, ADAMTS-3 
and ADAMTS-14 (Colige et al. 1997, 2002, Fernandes et al. 2001). 
8. Fibril assembly: Fibril formation starts after removal of the globular N and C propeptides 
from procollagen by the procollagen N- and C-proteinases (Leung et al. 1979) (Fig 1.5). 
Cleavage of the C-propeptides reduces the solubility of the protein and the collagen molecules 
self-assemble into fibrils (Kadler et al. 1987, Prockop & Hulmes 1994, Canty & Kadler 2005). 
After assembly of the collagen molecules into fibrils, covalent cross-links are formed and these 
provide the fibrils with their tensile strength and mechanical stability. The crosslinks are formed 
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from lysine and hydroxylysine derived aldehydes that are synthesized in a reaction catalyzed by 
lysyl oxidase (Prockop & Kivirikko 1995), which causes the oxidative deamination of the ε-
amino group in certain lysine and hydroxylysine residues (Kagan & Trackman 1991). The 
crosslinks formed from a hydroxylysine derived aldehyde are more stable than those formed 
from a lysine derived aldehyde (Prockop & Kivirikko 1995). A characteristic feature of the fibril 
forming collagens is that they form highly ordered, quarter-staggered, 67 nm banded fibrils, i.e. 
adjacent molecules overlap by a distance of 67 nm or a multiple of this, with a 40 nm gap 
between the ends of the continuous non-overlapping molecules (Prockop & Kivirikko 1995, 
Bella et al. 1994). Collagen fibril diameters range from 20 to 500 nm, depending on the tissue 
and age. 
 
 
Fig 1.5 Overview of the steps involved in the production of collagen fibrils by fibroblasts. Procollagen chains 
are synthesized in the endoplasmic reticulum (ER), are brought together by interactions between the C-propeptides 
and fold to form a rod-like triple-helical domain flanked by globular N- and C-propeptides. Removal of the N- and 
C-propeptides from fully folded procollagen only occurs after transport of procollagen across the Golgi stacks and 
results in collagen molecules that are then able to assemble into fibrils. Covalent crosslinks occur within and 
between triple-helical collagen molecules in fibrils (Canty & Kadler 2005). 
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1.6 Collagen II 
Collagen II is the major cartilage collagen, but is also expressed in the vitreous of the eye and is 
detected during early embryogenesis in the cranial mesenchyme and sclerotome of the somites. 
Collagen II transcripts are further present in the axial and appendicular skeleton, in 
nonchondrogenic tissues such as notochord, neural retina, cornea and conjunctival epithelia and 
in the sclera of the developing eye (Brewton & Mayne 1992). Unexpectedly, localisation of type 
II collagen mRNA was also reported in the proliferative ventricular cells of the forebrain and 
midbrain of embryos and in the cervical spinal cord (Cheah et al. 1991). The gene that codes for 
the polypeptide chains of homotrimeric collagen II consists of 54 exons and is about 31 kb in 
size (Ala-Kokko & Prockop 1990, Ala-Kokko et al. 1995). Its chromosomal location is 
12q13.11-q13.12 (Takahashi et al. 1990). The sequence coding for the N-terminal propeptide 
contains an alternatively spliced exon that codes for a 69-amino acid cysteine-rich domain (Ryan 
& Sandell 1990). Collagen II molecules including (IIA) or excluding this domain (IIB) have 
distinct distributions in various stages of chondrogenesis, type IIA predominating in the 
prechondrogenic mesenchyme and differentiating chondrocytes, and type IIB in differentiated 
chondrocytes (Nah & Upholt 1991, Sandell et al. 1991). The collagen II molecules in the fibril 
overlap with each other by a distance of about a quarter of their length, thus forming a banded 
fibril. The molecules are covalently crosslinked between the triple helical domain and the N- or 
C-terminal telopeptides of adjacent collagen II molecules. Collagen II has a high capacity to 
withstand forces exerted. Indeed, it has a tensile strength comparable to steel and thereby 
strongly influences the biomechanical properties of cartilage (Vikkula et al. 1994). Due to the 
complexity of the folding and assembly, collagen II structure is susceptible to mutations leading 
to disease states that are collectively termed chondrodysplasias and possess a wide range of well-
characterised clinical phenotypes (Vikkula et al. 1994, Mundlos & Olsen 1997, Myllyharju & 
Kivirikko 2001). 
1.7 Chondrodysplasias 
Most chondrodysplasias are due to point mutations in the collagen II gene. Most of these result 
in the substitution of glycine in the Gly-X-Y repeats and thereby the stability of the triple helix is 
decreased. Mutations in the X or Y position in the peptide chain are less frequent. In addition, 
nonsense mutations occur which lead to premature termination of the chain. Deletions have also 
been reported, leading to severe pathological conditions (Vikkula et al. 1994, Mundlos & Olsen 
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1997, Myllyharju & Kivirikko 2001). Table 1.1 summarizes the known mutations and the 
resulting phenotype. A brief description of each phenotype is given below. 
 
Table 1.1 Types of chondrodysplasia caused by point mutations and the resulting amino 
acid exchanges in collagen II. Numbers indicate the position in the triple helical domain. 
 
Achondrogenesis II Hypochondrogenesis SEDC Stickler syndrome 
Gly253Asp 
Gly310Asp 
Gly313Ser 
Gly517Val 
Gly571Ala 
Gly571Asp 
Gly580Arg 
Gly595Arg 
Gly694Glu 
Gly748Asp 
Gly769Ser 
Gly781Ser 
Gly817Val 
Gly313Ser 
Gly517Val 
Gly571Ala 
Gly604Ala 
Gly691Arg 
Gly805Ser 
Gly853Glu 
Gly913Cys 
Gly988Arg 
Thr1190Asn 
Arg 75 Cys 
Arg789Cys 
Gly973Arg  
Gly997Ser 
Arg9Term 
Gly 67Asp 
Arg365Cys 
Leu467Phe 
Gly506Term 
Arg519Cys 
Arg585Term 
Arg704Cys 
Arg732Term 
 
SEDC, Spondylo Epiphyseal Dysplasia Congenita; Term, Termination 
Mutations in bold are used in the present study 
 
1.8 Achondrogenesis type II and hypochondrogenesis (OMIM 200610) 
Achondrogenesis type II and hypochondrogenesis were considered two separate disorders 
(Langer et al. 1969, Saldino 1971, Maroteaux et al. 1983). After individuals with an intermediate 
phenotype have been characterized they are defined as different degrees of severity of the same 
disorder (Borochowitz et al. 1986). Infants die perinatally or within the first weeks of life. The 
disorder is characterized by a short, barrel-shaped trunk, very short extremities, large head, soft 
cranium, flat face and hydropic appearance. Radiographically, the affected infants show varying 
degrees of underossification of the axial skeleton. Histological and electron microscopic 
examinations reveal hypercellular epiphyseal cartilage with poorly organized or absent growth 
plate and diminished extracellular matrix that contains thick, irregular collagen fibrils together 
with large chondrocytes with a dilated rough endoplasmic reticulum. Biochemical studies of 
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hyaline cartilage from these infants have indicated abnormal and diminished collagen II (Eyre et 
al. 1986, Godfrey et al. 1988, Godfrey & Hollister 1988, Spranger et al. 1994.). The genetic 
defect leading to this pathology was found in the COL2A1 gene (Vissing et al. 1989). Table 1.1 
lists various mutations leading to achondrogenesis II.  All of them involve the replacement of 
glycine by a bulkier amino acid in the triple helical region of the 1(II) chain.  
1.9 Spondyloepiphyseal dysplasia and congenital 
spondyloepiphyseal dysplasia (SEDC, OMIM 183900) 
Spondyloepiphyseal dysplasia is characterized by short trunk, short extremities, barrel-shaped 
chest, kyphosis, severe myopia, retinal detachments, cleft palate and clubfoot (Fig 1.6A). 
Radiographs (Fig 1.6B) show defects in ossification of the spine and primarily proximal 
extremities (Mortier et al. 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.6 Phenotype of SEDC patients. (A) Disproportionate short stature with short trunk, enlarged joints, high 
forehead, frontal bossing, pectus carinatum deformity and radiological findings of anteroposterior and lateral spine 
radiographs shows: thoracic scoliosis, accentuated lumbar lordosis, flattened and dysplastic vertebral bodies 
(Sobetzko et al 2000). (B)  Anteroposterior radiographs of patients representing a severe phenotype characterised by 
short tubular bones with metaphyseal irregularities, minimal ossification of vertebral bodies in the thoracic spine, 
hypoplastic iliac wings with flat acetabular roofs, short ribs along with shortened tubular bones, flattened but 
normally ossified vertebral bodies, normal acetabular roofs, and a less narrow chest (Mortier et al 2000). 
 
A B 
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Histological studies show defects resembling those in achondrogenesis type II-
hypochondrogenesis and biochemical examination indicates abnormalities in collagen II (Murray  
et al. 1989). SED refers to a heterogeneous group of disorders that affect the spine and 
epiphyses, and as the symptoms resemble those of achondrogenesis type II-hypochondrogenesis, 
SED can be considered to represent the mild end of the spectrum comprising achondrogenesis 
type II-hypochondrogenesis and SED phenotypes (Spranger et al. 1994). Most cases of SED 
show autosomal dominant inheritance, but an autosomal recessive form of inheritance has also 
been suggested in some cases (Harrod et al. 1984). Lee et al. (1989) identified a deletion of an 
entire exon in the COL2A1 gene, leading to a lack of 36 amino acids in the triple helical region 
of the chain, and subsequently numerous mutations, including insertions, mutations causing 
aberrant RNA splicing, glycine mutations and a cysteine for arginine substitution, have been 
characterized (Vikkula et al. 1994, Kuivaniemi et al. 1997). However, some investigations have 
excluded the COL2A1 gene as a locus for SED in certain families, indicating that there must also 
be some other locus or loci for the disorder (Wordsworth et al. 1988, Anderson et al. 1990). 
SEDC is of autosomal dominant inheritance and affects the vertebrae, juxtatruncal epiphyses and 
leads to a lack of ossification of pubis, distal femoral and proximal tibial epiphyses, talus and 
calcaneues, flattening of vertebral bodies, short limbs, cleft palate, mental retardation, myopia 
etc. (Gunthard et al. 1995). Previous studies indicate that the processing and assembly of 
collagen is disrupted but the exact mechanism of pathogenesis is yet to be unraveled. 
1.10 Stickler syndrome (OMIM 108300) 
Stickler syndrome, originally called hereditary progressive arthroophthalmopathy, is an 
autosomal dominantly inherited disorder and is caused by mutations in collagen II or collagen 
XI. The α 3 (XI) chain is the IIB splicing variant product of the COL2A1 gene (Wu & Eyre, 
1995). Phenotypically, it is characterised by progressive myopia and vitreoretinal degeneration 
resulting in retinal detachment and blindness. Midfacial hypoplasia and micrognathia are often 
accompanied by cleft palate or a lesser degree of clefting, and a sensorineural hearing defect is 
common (Fig 1.7). The skeletal manifestations include juvenile progressive arthropathy, 
irregularity of the vertebral bodies and hypermobile joints. Skeletal growth is usually normal. 
Mild epiphyseal dysplasia and overtubulation of long bones are seen in radiological examination 
(Temple 1989, Snead & Yates 1999). Linkage studies have shown that the COL2A1 gene is a 
locus for Stickler syndrome (Francomano et al. 1987, Knowlton et al. 1989). Altogether nine 
mutations have been reported to date, all of them leading to premature termination of translation 
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(Ahmad et al. 1991, Brown et al. 1992, Ahmad et al. 1993, Ritvaniemi et al. 1993, Brown et al. 
1995a, Ahmad et al. 1995, Williams et al. 1996). The COL2A1 gene has also been excluded in 
several families with Stickler syndrome (Knowlton et al. 1989, Vintiner et al. 1991, Bonaventure 
et al. 1992). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.7 Clinical phenotypes of patients with Stickler syndrome. (A) Probands with mild nasal root hypolasia, 
midfacial hypoplasia and slender digits. (B) Vitreous phenotypes displaying membraneous congenital vitreous 
anomaly, beaded appearance of vitreous and a fibrillar vitreous anomaly in comparison with normal vitreous 
(Richards et al. 2000, 2002a, 2002b). 
 
B 
 
A 
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Stickler families with congenital vitreous anomaly (Stickler syndrome type 1) have linkage to the 
COL2A1 gene, while in those with congenitally defective vitreous gel architecture but no 
congenital vitreous anomaly (Stickler syndrome type 2) linkage is excluded (Snead et al.1994).  
Subsequently, Richards et al. (1996) demonstrated linkage to the COL11A1 gene in a family 
with Stickler syndrome type 2, and traced it to a missense mutation converting glycine to valine 
in the N-terminal part of the triple helix of the α 1(XI) chain. In addition, Wilkin et al. (1998) 
have suggested still another locus for Stickler syndrome apart from the genes coding for 
collagens II and XI. It has also been reported that mutations in collagen II in the X position cause 
haploinsufficiency and that leads to reduced amount of collagen, resulting in characteristic 
membranous congenital anomaly in the vitreous (Snead et al. 1994, Snead and Yates 1999, 
Richards et al. 2000). 
1.11 Osteoarthritis (OMIM 165720) 
Osteoarthritis (OA) is the most common articular disorder, characterized by joint pain and 
tenderness, stiffness, crepitus and limitation of motion. Radiographs of patients indicate joint-
space narrowing, osteophytes, subchondral bone sclerosis and subchondral cyst formation. In 
severe cases, deformity of the bone ends is also seen. OA is classified into primary (idiopathic) 
or secondary subsets, in primary cases there is no known predisposing factor, while in secondary 
cases factors such as trauma, infection, some other joint disorder or a metabolic disease is 
indicated. Further classification divides OA into localized, in which only certain joints are 
affected, and generalized subsets. Even though OA is often considered an consequence of 
ageing, female sex, obesity, occupational load and heavy sports exertion are risk factors (Altman 
1995, Creamer & Hochberg 1997). The suggestion of genetic factors underlying OA in certain 
families was made several decades ago (Stecher et al. 1953, Kellgren et al. 1963). Palotie et al 
(1989) demonstrated a linkage to the COL2A1 gene in a family with primary OA. Knowlton et 
al. (1990) made a similar finding in a family with precocious OA and associated mild 
chondrodysplasia and Ala-Kokko et al. (1990) subsequently demonstrated a mutation in this 
family. The mutation converted arginine to cysteine, an amino acid not normally found in the 
triple helical domains of collagens, in the middle of the triple helix of the collagen II molecule. 
Altogether five families with this same mutation have been reported to date, and three of them 
have been shown to have a common ancestor (Bleasel et al. 1995, Kuivaniemi et al. 1997, 
Bleasel et al. 1998). In addition, a mutation converting arginine to cysteine at position 75, near 
the N-terminus of the triple helix, has been reported in three families with OA associated with 
mild SED (Bleasel et al. 1995, Bleasel et al. 1996). Osteoarthritis is also associated with 
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mutations in other non collagenous proteins; e.g. a missense mutation in the epidermal growth 
factor-like domain in matrilin-3 leading to OA in several families.  (Stefansson et al. 2003). 
Kizawa et al. (2005) identified polymorphism in asporin that suppressed TGF-β-mediated 
expression of the genes coding for aggrecan (AGC1) and type II collagen (COL2A1) 
accompanied with reduced proteoglycan accumulation leading to osteoarthritis. Similar forms of 
osteoarthritis were reported to be due to functional variants within the secreted frizzled-related 
protein 3 gene (Loughlin et al. 2004). 
1.12 Animal models for chondrodysplasias due to collagen II 
mutations 
Transgenic mice carrying a partially deleted human COL2A1 gene developed the phenotype of a 
chondrodysplasia with dwarfism, short and thick limbs, short snout, cranial bulge, cleft palate, 
and delayed mineralization of bone (Vandenberg et al. 1991). In cultured chondrocytes from 
transgenic mice, the minigene was expressed as shortened pro-α-1(II) chains that were disulfide-
linked to normal mouse type II collagen chains. Therefore, the phenotype was probably 
explained by depletion of endogenous mouse type II procollagen through the phenomenon of 
procollagen suicide. Transgenic mice harboring a glycine-to-cysteine mutation at residue 85 of 
the triple helical domain of mouse type II collagen displayed severe chondrodysplasia with short 
limbs and trunk, craniofacial deformities, and cleft palate (Garofalo et al. 1991). Electron 
microscopic analysis showed a pronounced decrease in the number of typical thin cartilage 
collagen fibrils, distention of the rough endoplasmic reticulum of chondrocytes, and the presence 
of abnormally large banded collagen fibril bundles. Garofalo et al. (1991) postulated that the 
abnormally thick collagen bundles were related to a defect in crosslinking.  
A transgenic mouse model of SEDC carrying collagen II transgene with an R789C mutation, in 
combination with a murine Col2a1 promoter directing the gene expression to cartilage, displayed 
overall short stature, had shorter limbs with disorganized growth plates, a short nose, cleft palate, 
and died at birth (Gaiser et al. 2002). The cellular organization of the cartilage architecture was 
profoundly disturbed in the transgenic growth plate, although the overall polarity was 
maintained. There were fewer stacks of flattened chondrocytes in the proliferative zone of the 
transgenic mouse growth plates. In addition to the abnormal cartilaginous tissue, the 
perichondrium was thicker and electron microscopy revealed a marked reduction of collagen 
fibrils in cartilage matrix from transgenic compared with that of wild-type mice. Increased 
distension of rough endoplasmic reticulum was observed in these chondrocytes. Using cell 
culture experiments and molecular modeling, Gaiser et al. (2002) suggested that this Y-position 
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mutation acts in a dominant-negative manner, resulting in destabilization of collagen molecules 
during assembly and reduction in the number of fibrils formed. 
1.13 Arginine to cysteine mutations 
The majority of chondrodysplasia-causing missense mutations in COL2A1 are substitutions of 
obligatory glycine residues in the triple helical domain. Only a few non-glycine missense 
mutations have been reported and among these, the arginine to cysteine substitutions 
predominate. In addition to the above R75C and R789C substitution (Table 1.1), recently two 
additional mutations (R365C and R1076C) were found in unrelated probands (Hoornaert et al. 
2005). 
Most of these chondrodysplasias are due to point mutations in the collagen II gene, altering the 
amino acid sequence in a way which destabilizes the triple helix. In addition, nonsense mutations 
have been detected which lead to premature termination of the chain. Deletions have also been 
reported leading to severe pathological conditions. 
 Point mutations leading to a change from arginine to cysteine are interesting since different 
mutations of this kind cause two well characterized clinical phenotypes, i.e Stickler syndrome 
and congenital spondyloepiphyseal dysplasia (SEDC) and osteoarthritis-associated SED. It is 
being speculated that Stickler syndrome can be caused by amino acid substitutions in the X 
position of Gly-X-Y repeats (Richards et al 2000) and substitutions in the Y position rather lead 
to SEDC. One of the notions derived from previous studies on mutations in collagen I is that the 
mutant molecules are intracellularly degraded leading to a reduction in the pool of extracellular 
collagen molecules available for the formation of correct collagen fibrils. Another hypothesis is 
that some of the mutant collagens are incorporated into collagen fibrils, thereby affecting their 
biomechanical characteristics (Royce & Steinmann 2002). 
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1.14 Aims of the thesis 
The mechanisms by which point mutation in collagen II cause damage to the structure of 
connective tissues are not fully understood, and some of the proposed pathways leading from a 
mutant genotype to a phenotype are controversial.  
The aims of this thesis were therefore: 
 
1. To investigate the effects of arginine to cysteine mutations in collagen II and to 
determine how these may lead to different clinical phenotypes. 
 
2. To analyze the biochemical consequences of arginine to cysteine substitutions found in 
patients with Stickler syndrome and SEDC. 
 
3. To determine the importance of the position of point mutations within the triple helical 
domain (towards the N- or C-terminal of the triple helix) with respect to triple helical 
integrity and overall collagen structure.  
 
4. To elucidate the effects of these point mutations on protein trafficking, secretion and cell 
survival.  
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2 Materials and methods  
2.1 Materials 
Standard chemicals and enzymes were if not otherwise mentioned purchased from Merck 
(Darmstadt), Sigma (Taufkirchen), Invitrogen (Karlsruhe), Biozym (Oldendorf), Roche 
(Mannheim) or New England Biolabs (Schwalbach). 
2.1.1 Enzymes for molecular biology 
Calf intestinal alkaline phosphatase (NEB) 
M-MLV reverse transcriptase (Promega) 
Restriction endonucleases (NEB) 
Ribonuclease A (Sigma) 
T4 DNA ligase (NEB) 
Taq DNA polymerase (Roche) 
2.1.2 Materials for cell culture 
Dulbecco’s Modified Eagle Medium (DMEM-F12), Invitrogen 
Non-essential Amino Acids (NEA), Invitrogen 
L-Glutamine (200 mM), Invitrogen 
Penicillin/Steptomycin, Invitrogen 
Fetal Bovine Serum (FBS), Biochrom KG, Berlin 
2.1.3 Plasmid and adenoviral vectors 
2.1.3.1. pBluescript KS+ (pBS KS+) phagemid 
The phagemid vector pBluescript KS+ (pBS KS+) was used for subcloning and was the basic 
vector used for site directed mutagenesis. Fig. 2.1 shows the map of pBS KS+ vector. The 
complete manual and sequence information for this vector are available from Stratagene at 
http://www.stratagene.com/manuals/212205.pdf. 
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Fig. 2.1 Map of the cloning vector pBS KS+. It consists of an f1 and PUC origin of replication (pUC ori), an 
ampicillin resistance ORF and a multiple cloning site (MCS) flanked by restriction sites for Kpn I and Sac I. 
2.1.3.2. pSL1180 superlinker phagemid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.2 Map of the superlinker phagemid pSL1180. It consists of an ampicillin resistance (Ampr) ORF, an M13 
origin of replication and a multiple cloning site. The multiple cloning site and restriction sites are shown in detail. 
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The phagemid vector pSL1180 was used for subcloning of collagen II cDNA after site directed 
mutagenesis and to remove the endogenous signal peptide. Fig. 2.2 shows the map of pSL1180 
vector with details of multiple cloning sites. A complete description and sequence informations from 
Amersham Biosciences can be found at http://www4.amershambiosciences.com/-
aptrix/upp01077.nsf/Content/Products? OpenDocument&parentid=41175&moduleid=41179. 
2.1.3.3 Eukaryotic expression vector pCEP-Pu 
The mammalian expression vector pCEP-Pu is a derivative of the pCEP-3 vector (Invitrogen) 
now containing a BM-40 signal peptide and a puromycin resistance (Kohfeldt et al 1997). In 
addition an enterokinase cleavage site was introduced between the sequence coding for the his6-
myc tag and the multiple cloning site (Wuttke et al 2001). This vector was used for expression of 
all collagen II variants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.3: Map of the eukaryotic expression vector pCEP-Pu (Wuttke et al 2001). This vector contains the signal 
peptide from BM-40 (BM-40 SP), a his6-myc-tag, the site for protease digestion by enterokinase (EK) and multiple 
cloning site between the CMV promoter and the SV 40 polyadenylation signal (pA). 
2.1.3.4. Adenoviral vector pGS66 and shuttle vector pGS70 
The adenoviral vector pGS66 and the shuttle vector pGS70 were kindly provided by G. 
Schiedner and S. Kochanek from the Center for Molecular Medicine, University of Cologne, 
Germany (Schiedner et al. 2000). The adenoviral vectors were used for transfection of primary 
chondrocytes. 
BM-40 SP- his6-myc-EK-collagen II cDNA 
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Collagen II cDNA from pCEP-Pu and pGS70 vector was digested with Hind III and Bam HI. 
After separation by electrophoresis the collagen II cDNA was purified using a gel purification 
kit. The linearised vector pGS70 was dephosphorylated and purified. Equimolar amounts of 
vector and insert were used for ligation.  
Fig.2.4: Map of adenoviral vectors used for cloning collagen II cDNA. (A) Map of the first generation adenoviral 
vector pGS66 with an ampicillin resistance (ampr) ORF, an adenoviral internal terminal repeats and a Pac I site for 
cloning the insert. (B) Map of pGS70 vector with a multiple cloning site for use with different enzymes, a SV40 
origin of replication and antibiotic resistance markers for kanamycin (Kanr) and neomycin (Neor). 
Collagen II cDNA was released from the vector pGS70 by digesting with the restriction enzyme 
Pac I. The vector pGS66 was also digested with Pac I and dephosphorylated to avoid self 
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ligation. Equimolar amounts of vector and insert were used for ligation. 10 µl ligation mixture 
was used for transformation and colonies obtained were screened for the insert by restriction 
digestion of the plasmid. 
2.2 Molecular biology methods  
2.2.1 Plasmid DNA isolation from E. coli  
Plasmid DNA was prepared from small scale bacterial cultures. Bacteria were lysed by treatment 
with a solution containing 1% SDS and 0.5 M NaOH. SDS denatures bacterial proteins and 
NaOH denatures chromosomal and plasmid DNA. The mixture was neutralized with potassium 
acetate, causing the plasmid DNA to reanneal rapidly. Most of the chromosomal DNA and 
bacterial proteins remain in the precipitate, as does SDS forming a complex with the potassium, 
and are removed by centrifugation. The reannealed plasmid DNA from the supernatant was 
concentrated by ethanol precipitation.  
2.2.2 Pure MIDI plasmid DNA isolation  
Highly pure plasmid preparations were purified on either a small or a large scale using kits from 
Macherey-Nagel (Nucleobond AX kit for small scale plasmid preparations) or Qiagen (Qiagen 
Midi and Maxi Prep kit for large scale plasmid preparations). Briefly, overnight cultures of 
bacteria, grown in the presence of an antibiotic marker for the plasmid DNA, were pelleted and 
the cells were lysed by alkali. The supernantant containing plasmid DNA was passed over silica 
columns whereby the DNA was bound to the matrix and the impurities and digested RNA were 
washed off. The plasmid DNA was eluted and concentrated by ethanol precipitation. Highly pure 
plasmid DNA obtained was washed with 70% ethanol to remove salts and further reconstituted 
in TE buffer. This plasmid DNA was used for site directed mutagenesis, PCR, sequencing and 
transfection of eukaryotic cells. The protocols were as described by the manufacturer.  
2.2.3 DNA agarose gel electrophoresis  
10X DNA loading buffer 
40% w/v sucrose 
0.5% w/v SDS    
0.25% w/v bromophenol blue 
in TE buffer pH 7.4  
50X Tris acetate buffer (1000 ml)  
242.2 g Tris 
57.5 ml acetic acid 
100 ml of 0.5 M EDTA 
pH 8.0, adjusted with NaOH 
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TE Buffer 
10 mM Tris-HCl  
1 mM EDTA 
pH 7.4 
 
Agarose gel electrophoresis to resolve and purify DNA fragments was performed according to 
the method described by Sambrook et al. (1989). Electrophoresis was typically performed with 1 
% (w/v) agarose gels submerged in a horizontal electrophoresis tank containing 1x TAE buffer at 
1-5 V/cm. For resolving fragments less than 1,000 bp, 2.5 % (w/v) agarose gels in 1x TAE buffer 
were used. DNA size marker (Life Technologies) was always loaded along with the DNA 
samples in order to estimate the size of the resolved DNA fragments. The gel was run until the 
bromophenol blue dye present in the DNA loading buffer had migrated the appropriate distance. 
The gel was examined under UV light at 302 nm and was photographed using a gel 
documentation system. 
2.2.4 Elution of DNA fragments from agarose gels 
Elution of DNA fragments from agarose gels was performed using UltraCleanTM15 (MO BIO 
LABS Inc) DNA purification kit. DNA bands of interest were cut out of the gel along with a 
minimal amount of agarose and then solubilised in binding buffer at 50 °C. This solution 
containing DNA was incubated with a silica matrix suspension to bind the DNA which was 
subsequently centrifuged and washed to remove unbound material. Pure DNA was isolated by 
incubating the silica matrix DNA pellet with low salt alkaline elution buffer. 
2.2.5 Measurement of DNA and RNA concentrations  
Concentrations of DNA and RNA were estimated by determining the absorbance at 260 nm and 
280 nm. A ratio of 1.8 indicates negligible protein contaminations.   
2.2.6 Restriction digestion of DNA  
Digestions were performed using restriction enzymes with the desired buffer and temperature as 
suggested by the manufacturers. Routinely 1-2 µg of plasmid DNA was digested for 1-2 h. 
2.2.7 Dephosphorylation of 5´ends of linearized vectors  
To avoid self-ligation of the vector having blunt ends or having been digested with a single 
restriction enzyme, the 5’ ends of the linearised plasmids were dephosphorylated by calf 
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intestinal alkaline phosphatase (CIP). Briefly, 1 µg DNA was suspended in the supplied NEB 
buffer before 1.0 U CIP was added and incubated for 60 min at 37 °C. DNA was purified by 
agarose gel electrophoresis.  
2.2.8 Ligation reaction 
The desired DNA fragment and the appropriate linearised plasmid were mixed in approximately 
equimolar amounts. T4 DNA ligase and ligation buffer containing ATP were added as indicated 
below and the ligation reaction left overnight at 10-12 ºC. 
Ligation reaction 
Linearised vector  
DNA fragment  
2 µl 10X ligation buffer 
1.5 U T4 ligase 
add H2O to make 20 µl 
2.2.9 Polymerase chain reaction (PCR)  
PCR can be used for in vitro amplification of DNA fragments (Saiki et al., 1985). A double 
stranded DNA (dsDNA) serving as a template, two oligonucleotides (primers) complementary to 
the template DNA, deoxyribonucleotides and heat resistant Taq polymerase are required for this 
reaction. Primers are designed as required (Table 2.1). The first step in PCR reactions involves 
the denaturing of dsDNA at 95 °C. Second, the reaction mix is incubated at different annealing 
temperatures, depending on the G/C content of the primers. The third step is the elongation step 
with a temperature of 68-72 °C that allows the elongation of the new strand of DNA by the Taq 
polymerase. A PCR machine (thermocycler) can be programmed to regulate these different 
cycles automatically. A “standard program” is presented in the table 2.2. 
 
Table 2.1 Primers and primer sequences used in the present study 
primer name sequence 
XBP-1F 5'-GGAGTTAAGACAGCGCTTGG-3' 
XBP-2R 5'-ACTGGGTCCAAGTTGTCCAG-3' 
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Table 2.2 Standard PCR programme used in the present study 
step cycles temperature time 
Initial denaturation 1 95 °C 1 min 
Denaturation 25-35 95 °C 50 s 
Annealing  25-35 55-68 °C 50 s 
Elongation 25-35 68 °C 1-15 min 
Final elongation 1 68 °C 7 min 
Cooling  1 4 °C  
 
2.2.10 Collagen II cDNA and patient derived mutations 
Human collagen II cDNA of 4.5 kb including the poly adenylation signal was kindly provided by 
Fibrogen Europe. In the present work, the shorter isoform of collagen II was used (Nah & Upholt 
1991, Sandell et al. 1991). Table 2.3 summarizes the patient based and artificial mutations which 
were selected for this study, all mutations selected lie in the triple helical domain of the protein.  
Table 2.3 Selected mutations used for the present study. The number represents the amino acid 
position from the start of triple helical region. 
position in Gly-X-Y X  Y  
 position amino acid exchange position amino acid exchange 
 134* Arg → Cys 75a Arg → Cys 
 704b Arg → Cys 789c Arg → Cys 
 740* Arg → Cys   
* artificial mutation, a Williams et al 1993, b Ballo et al 1998, c Chan et al 1993 
2.2.11 Subcloning of collagen II cDNA 
Due to the size of the full length cDNA, collagen II cDNA was subcloned into smaller fragments 
which were ligated into pBluescript KS+ vector and used for site directed mutagenesis. After 
confirmation of the positive clones by restriction analysis and sequencing, the insert was removed 
and ligated back into the original vector to obtain the complete collagen II cDNA backbone with the 
desired mutation. The subcloning strategy is illustrated in figure 3.1.  
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2.2.12 Site directed mutagenesis 
Site directed mutagenesis was carried out using the XL Quick Change mutagenesis kit from 
Stratagene following the manufacturers protocol. Fig 2.5 illustrates the procedure. In brief, 
mutagenesis was carried out by designing specific primers carrying single or double nucleotide 
changes in the middle of the primers leading to the mutation of interest. After sequencing of the 
wild type collagen II cDNA an unwanted mutation at codon 52 with a histidine in place of proline 
was identified. Since this mutation lies in the N-propeptide region, there was a need to correct it by 
site directed mutagenesis. Primers were designed (His Pro) possessing the desired change along 
with a silent mutation leading to a new restriction site Xma I, which facilitate identification of 
positive clones by restriction digestion. The primers used for respective site directed mutagenesis 
are listed in the table 2.4. 
Table 2.4 Primer pairs used for site directed mutagenesis 
primer name sequence 
 75F 5’-GGTCCTCAGGGTGCTTGTGGTTTCCCAGG-3’ 
 75R 3’-CCTGGGAAACCACAAGCACCCTGAGGACC-5’ 
 134F 5’-CTGGTGAAAGAGGATGCACTGGCCCTGCTG-3’ 
 134R 3’-CCAGCAGGGCCAGTGCATCCTCTTTCACC-5’ 
 704F 5’-GGAGCTGCTGGGTGCGTTGGACCCCC-3’ 
 704R 3’-GGGGGTCCAACGCACCCAGCAGCTCC-5’ 
 740F 5’-CCCCCTGGCTGCGCTGGTGAACCCGG-3’ 
 740R 3’-GGGTTCACCAGCGCAGCCAGGGGGG-5’ 
 789F 5’-GGTCTGCCTGGGCAATGTGGTGAGAGAGGATTCC-3’
 789R 3’-GGAATCCTCTCTCACCACATTGCCCAGGCAGACC-5’ 
 His ProF 5’-GACCCAAAGGACCTCCCGGGCCTCAGGG-3’ 
 His ProR 3’-CCCTGAGGCCCGGGAGGTCCTTTGGGTC-5’ 
Numbers 75, 134, 704, 740 and 789 stand for the amino acid residue numbered from the start of the triple helix 
where the mutation of interest is located. His Pro stands for the primers used to correct the unwanted mutation 
histidine to proline (see details in the text). Nucleotides marked in bold indicate the nucleotide change to introduce 
the mutation of interest. 
 
The tubes were gently mixed and a standard PCR was run as shown in Table 2.1 with 18 cycles 
using an annealing temperature of 60 °C for 50 s and an elongation step of 15 min at 68 °C in 
each cycle. A final elongation step at 68 °C for 7 min was followed. After the PCR reaction, the 
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enzyme Dpn I was added to each tube to digest the parental DNA and samples were incubated 
for 2 h at 37 °C. 
Table 2.5 Standard reaction mixture for site directed mutagenesis.  
compound amount 
10X reaction buffer 5.0 µl 
cDNA template 2.0 µl (40 ng) 
primer F 1.25 µl (125 ng) 
primer R 1.25 µl (125 ng) 
dNTP mix (10 mM) 1.0 µl 
Quick solution 3.0 µl 
dd H20 36.5 µl 
Pfu Turbo DNA polymerase 1.0 µl 
 
10 µl of each sample was run on a 1% agarose gel. Another 10 µl was used for transformation of 
XL10 – Gold ultracompetent cells (Stratagene) and SURE cells. In brief, the ultra competent 
cells were thawed on ice. 2 µl of ß-mercaptoethanol was added to 25 µl of each cell suspension, 
swirled gently and incubated on ice for 10 min with occasional swirling. 10 µl of Dpn I digested 
DNA was added to the cells, swirled gently to mix and incubated for 30 min on ice, heat pulsed 
for 30 s at 42 °C and incubated again for 2 min on ice. Finally 0.5 ml of LB or SOC medium was 
added and incubated at 37 °C for 1h at 250 rpm shaking. 200 µl of the transformation mixture 
was plated on a LB-ampicillin agar plate and incubated at 37 °C for at least 16 h. 
 
SOC medium 
20 g Bacto-tryptone  
5 g Bacto-yeast extract  
0.5 g NaCl    
2.5 ml 1 M KCl    
add H2O to make 1000 ml 
pH to 7.0 with 10 N NaOH 
add 20 ml of sterile 1 M glucose before 
use after autoclaving 
Luria-Bertani (LB) Medium 
10 g Bacto-tryptone 
5 g Bacto-yeast extract 
10 g NaCl 
add H2O to make 1000 ml 
Autoclave 
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Fig. 2.5: Schematic representation of XL10 quick change site directed mutagenesis. A detailed description of 
the figure is explained in the text. 
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2.2.13 Removal of the collagen II signal peptide 
Before cloning into the mammalian expression vector pCEP-Pu, the signal peptide of collagen II 
cDNA had to be removed since pCEP-Pu bears a BM-40 signal peptide. Primers (Table 2.6) 
were designed to have the Nhe I overhangs at the 5’ end of the forward primer and start of 
collagen II cDNA without the signal peptide. The reverse primer was 1.4 kb downstream. The 
PCR product was cloned into pBS KS+ vector after digesting both the PCR product and the 
vector with Nhe I and Sac II. This insert after sequencing was excised from the vector and 
cloned into collagen II cDNA which was excised from pBS KS+ vector by Spe I and EcoR V 
and cloned into pSL 1180 vector.  
Table 2.6. Primers used for deletion of the signal peptide sequence from the collagen II 
cDNA 
 primer name sequence 
 Nhe I SP-F 5’-GCCGCTAGCCCAGGATGTCCGGC-3’ 
 Sac II-R 3’-GGAAACCGCGGTTGCCGGGAGC-5’ 
2.2.14 Screening for recombinants and sequencing  
Colonies obtained were individually picked and inoculated into sterile LB media containing 200 
µg/µl of ampicillin and were allowed to grow for 12 h. Plasmid DNA was isolated by a slightly 
modified method based on a commercially available Qiagen kit as per the manufacturer’s 
instructions. 2 µl was used to check for size and purity on a 1% agarose gel and further 
confirmation obtained by restriction digestion. 1 µl of the plasmid preparation was mixed with 1 
µl of primer (125 ng) and sequenced at the service facility of the Centre for Molecular Medicine, 
University of Cologne by modified dideoxy nucleotide termination method using a ‘Perkin 
Elmer ABI prism 377’ DNA sequencer. 
2.2.15 Eukaryotic expression vector 
pCEP-Pu with an N-terminal his6-myc tag was used as the basic mammalian expression system 
(Wuttke et al. 2001). Wild type and mutated collagen II cDNA was excised from pSL1180 using 
Nhe I and Bam HI and then ligated into the pCEP-Pu expression vector which was digested with 
the same enzyme and dephosphorylated. 10 µl ligation mixture was transformed into SURE cells 
and plated these on LB agar plates containing ampicillin and grown overnight. Colonies were 
picked and the plasmid isolated from 2 ml cultures. These clones were screened by restriction 
digestion and positive clones sequenced. 
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2.2.16 RNA isolation from cultured HT1080 cells 
Total RNA was isolated from transfected HT1080 cells grown in 6 well plates using the TRIZOL 
reagent (Invitrogen) as per the manufacturer’s instruction. Briefly, 3 x 105 cells which were 
transfected in six well plates were rinsed with PBS and 1 ml of TRIZOL reagent was added to 
lyse the cells. This homogenate was transferred to an RNase free microfuge tube and incubated 
for 5 min at room temperature to permit the complete dissociation of nucleoprotein complexes.  
0.2 ml of chloroform per 1 ml of TRIZOL reagent was added, mixed well by vortexing for 15 s 
and incubated for 2 to 3 min. Samples were centrifuged at 12,000 g for 15 min at 2 °C. During 
centrifugation the mixture separated into a lower red phenol-chloroform phase, an interphase, 
and a colorless upper aqueous phase. RNA remained exclusively in the aqueous phase which was 
carefully transferred to a fresh tube without transferring any of the interphase material. RNA was 
precipitated from the aqueous phase by mixing with 0.5 ml isopropyl alcohol and incubating the 
samples at room temperature for 10 min followed by centrifugation at 12,000 g for 10 min at 2 
°C. The RNA precipitate obtained was washed with 70% ethanol to remove all traces of 
isopropanol and centrifuged again. The RNA pellet was reconstituted in 20 µl of DEPC water.  
2.2.17 Reverse transcription  
Isolated RNA was converted into cDNA using reverse transcriptase (Superscript II, Invitrogen) 
and an Oligo-dT-Primer. 2 µl of total RNA was mixed with 25 µM Oligo-dT-Primer and the 
volume adjusted to 12 µl with DEPC water. Secondary structures in the RNA were removed by 
incubating for 10 min at 70 °C and then cooling on ice. The reaction mixture containing 0.5 µl 
reverse transcriptase (200 U/µl), 4 µl enzyme buffer, 0.5 µl RNase-inhibitor (40 U/µl, Roche), 1 
µl dNTP mix (10 mM mix of  dATP, dGTP, dCTP, dTTP) und 2 µl 0.1 % DTT  was added and 
incubated for 50 min at 42 °C. The reaction was stopped by denaturing the enzyme by heating to 
72 °C. cDNA obtained was frozen at -20 °C and 1 µl of this cDNA was used for polymerase 
chain reaction. 
2.3 Cell biology methods 
2.3.1 Cell culture and maintenance of 293 EBNA and HT1080 cells  
293 EBNA cells (Invitrogen) derived from human embryonic kidney and HT1080 (CCL-121 
from ATTC) cells derived from human fibrosarcoma were cultured in DMEM-F12 containing 
200 U/ml penicillin, 200 µg/ml streptomycin, 20 mM L-glutamine and 10 % FBS (Biochrom), 
from now on referred to as standard medium, at 37 °C in a humified incubator with a 5 % CO2 
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atmosphere. Media were supplemented with 100 µg/ml ascorbate during expression of 
recombinant collagens since ascorbate acts as a cofactor for proline hydroxylation during 
collagen biosynthesis.  
2.3.2 Transfection 293 EBNA and HT1080 cells with FuGene6  
6 µl of FuGene6 (Roche) reagent was added to a microfuge tube containing 94 µl of serum free 
medium, after 5 min incubation this solution was added to another microfuge tube containing 1 
µg of plasmid DNA. The reaction mixture was mixed well and incubated for 15 min at room 
temperature. The suspension was again mixed and added dropwise on to cells which were at 70 
% confluency. After 24 h fresh medium was added, containing 1 µg/ml puromycin if the cells 
were to be selected. 
2.3.3 Isolation and culture of bovine chondrocytes   
Bovine humeroscapular joints of 18–24 month old animals were obtained from the local 
slaughterhouse. Aseptically, cartilage tissue was exposed, scraped and collected. Chondrocytes 
were isolated by sequential digestion with pronase (0.4 % w/v; 1.5 h at 37°C) and collagenase P 
(0.025% w/v; overnight at 37 °C) in DMEM containing 5% v/v FBS and 50 µg/ml gentamicin. 
The isolated chondrocytes were plated at a density of 3×104 cells/cm2. After reaching confluency 
cells were subcultured twice a week and grown in standard medium containing ascorbate. 
2.3.4 Passaging of cell lines 
When the cells had grown to confluency cell culture media were aspirated and the cells washed 
once with sterile phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 4.3 mM 
Na2HPO4 7H2O, 1.4 mM KH2PO4, pH 7.4) to remove all traces of serum that contains trypsin 
inhibitor. Cells were detached from the surface using a minimal volume of 0.05% trypsin and 
0.02% EDTA in PBS, pH 7.4. Cells that were difficult to detach were placed at 37 °C to 
facilitate dispersal, fresh growth medium supplemented with serum added to neutralize the action 
of trypsin and cells aspirated by gentle pipetting. If required, cells were counted before 
aliquoting into new culture vessels or split 1:4 during routine cell culture. Cultures were 
incubated at 37 °C. 
2.3.5 Freezing cells for storage 
Cells were trypsinised, resuspended in growth medium supplemented with 20% FBS and 10% 
DMSO (Sigma-Aldrich) which acts as cryoprotectant. Cells were transferred into cryotubes 
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which were slowly cooled down to -80 °C in a cryobox containing isopropanol.  24 hours later 
they were placed in liquid nitrogen for longer conservation.  
2.3.6 Thawing of frozen cells  
Frozen cryotubes containing the cells were rapidly defrosted in a 37 °C water bath. The thawed 
cell suspension was diluted in standard medium and centrifuged at 1000 g for 5 mins to remove 
DMSO. The cells were then resuspended in fresh standard growth medium.  
2.3.7 Cell counting  
Cells were trypsinised, collected by centrifugation (1000 g, 5 min) and resuspended in a small 
volume of medium. A 10 µl aliquot was introduced in a Neubauer’s chamber with a pipette, cells 
counted and the cell number per ml calculated. 
2.3.8 Immunofluorescence staining 
Sterile glass cover slips were washed with 1 N HCl, sterile water and 70% ethanol. After drying, 
they were placed in a 24 well culture plate and sterilized under UV light for 20 min. 25,000 cells 
were added into each well and grown overnight. Cells were transfected with Fugene6 as 
mentioned above and next day the media were replaced with fresh standard medium containing 
100 µg/ml ascorbate. Depending on the experimental requirements, cells were fixed either two or 
three days after transfection at room temperature with a freshly prepared 4% paraformaldehyde 
solution in PBS for 15 min and subsequently permeabilised with 1% Triton-X100 in PBS for 4 
min. Immediately, cells were washed three times with PBS followed by blocking with 1% 
normal goat serum (NGS) for 30 min to avoid unspecific binding of antibodies. Subsequently the 
fixed cells were incubated with the primary antibodies in PBS for 60 min and washed four times 
with PBS before applying the fluorochrome conjugated secondary antibodies in PBS for 60 min. 
Cells were washed three times with PBS to remove unbound secondary antibodies and incubated 
with bisbenzimide (Sigma, 0.1 µg/ml) for 5 min to stain the nuclei, followed by two additional 
washing steps to remove unbound bisbenzimide. Cover slips containing stained cells were 
carefully lifted from wells and mounted on histoslides with fluorescent mounting medium 
(DAKO). All the steps after adding secondary antibody were performed in dark. The list of 
primary and secondary antibodies used is shown in the table 2.7. 
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Table 2.7 List of primary and secondary antibodies used in immunofluorescence 
Antibody Dilution Company 
Primary antibodies   
Mouse monoclonal anti-c-myc 1:1000 Santa Cruz 
Rabbit polyclonal anti-c-myc 1:1000 Santa Cruz  
Mouse monoclonal anti-Golgi 58K protein 1:1000 Sigma 
Mouse monoclonal anti-PDI (ER marker) 1:1000 Stress Gene 
Rabbit polyclonal anti-Grp78 (BiP) 1:1000 Stress Gene 
Mouse monoclonal FITC conjugated rabbit anti-active 
caspase-3 
1:500 BD Biosciences 
Secondary antibodies   
Alexa 488 goat anti-rabbit IgG 1:1000 Molecular Probes 
Alexa 546 goat anti-rabbit IgG 1:1000 Molecular Probes 
2.3.9 Image analysis  
Immunofluorescence stainings were observed with an inverted fluorescence microscope. Digital 
images obtained were acquired with the Metamorph software and processed using Adobe 
Photoshop. 
2.3.10 Comet assay or single cell gel electrophoresis (SCGE) 
Fully frosted slides were precoated with 1 % solution of normal agarose in PBS and allowed to 
dry, this layer supports the attachment of the cell containing agarose layer. Single cell 
suspensions obtained by trypsinisation were counted, diluted to give approximately 5 x 104 
cells/ml and reduced to 100 µl volume by centrifugation. 80 µl of each final suspension was 
added to 400 µl of 0.5% low melting agarose maintained at 37 °C and 90 µl of this suspension 
was pipetted onto a precoated slide. An additional 1% low melting agarose layer without cells 
was added after solidification of the above layer. After solidification, the slides were placed in 
alkaline lysis solution (2.5 M NaCl, 100 mM EDTA, 10 mM Tris-HCl, 1% Triton X-100, 10% 
DMSO, pH to 10.0) and the cells were lysed in the dark at 4 °C for 1 h. Slides were then rinsed 
for 30 min in three changes of neutralizing solution (400 mM Tris-HCl, pH 7.5) to remove all 
detergents and salts. After rinsing, slides were placed side by side in a horizontal electrophoresis 
chamber containing freshly made electrophoresis buffer (300 mM NaOH, 1 mM EDTA, pH>13) 
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and incubated in the alkaline buffer for 20 to 60 min to allow unwinding of the DNA. The slides 
were subjected to electrophoresis at 0.6 V/cm for 30 min. Following electrophoresis, the slides 
were rinsed with neutralisation buffer twice, stained with 100 µl ethidium bromide solution (10 
mg/ml) and scored immediately or dried in cold 100 % ethanol before storage. Comets were 
visualized using an inverted fluorescence microscope and evaluated using TriTek CometScore™ 
software. 
2.3.11 Nick labelling  
Apoptosis was detected using the DeadEnd™ Fluorometric TUNEL System from Promega 
following a slightly modified manufacturer’s protocol. Briefly, four days post transfection cells 
were fixed by immersion in 4% paraformaldehyde solution for 25 min, washed twice in PBS for 
5 min and permeabilized by adding 0.2% Triton X-100 solution in PBS for 5 min.  After washing 
in PBS cells were incubated in 100 µl of equilibration buffer at room temperature for 5–10 min.  
Cells were incubated with 50 µl of reaction buffer (rTdT incubation buffer) at 37 °C for 60 min 
inside a dark humidified chamber to allow for the tailing reaction, which was terminated by 
adding 2X SSC for 15 min. Cover slips were washed with PBS twice to remove unincorporated 
fluorescein-12-dUTP. Bisbenzimide (0.1 µg/ml in PBS) was added for 5 min to stain the nuclei 
and cells were washed twice to remove unbound bisbenzimide. Cover slips were washed once 
with deionized water for 5 min at room temperature and excess water was drained and blotted 
with tissue paper. Cover slips were mounted on histoslides with DAKO mounting medium. 
 
Equilibration buffer 
200 mM potassium cacodylate (pH 6.6) 
25 mM Tris-HCl (pH 6.6) 
0.2 mM DTT 
0.25 mg/ml BSA 
2.5  mM cobalt chloride 
Nucleotide mix 
50 µM fluorescein-12-dUTP 
100 µM dATP 
10 mM Tris-HCl (pH 7.6) 
1 mM EDTA 
rTdT incubation buffer 
Combine the following: 
90 µl equilibration buffer 
10 µl nucleotide mix 
2 µl rTdT enzyme 
20X SSC 
87.7 g NaCl 
44.1 g sodium citrate 
pH 7.2 
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2.3.12 Transduction of chondrocytes and transgene expression 
First generation and high capacity gutless adenoviral particles were transduced by addition of 10 
to 1000 moieties of infection (MOI). This was added with 0.75 ml of fresh culture medium to 
each well of a six-well plate containing 3 x 105 adherent cells and incubated at 37 °C. Transgene 
expression in chondrocytes was monitored by the EGFP expression using fluorescence and phase 
contrast microscopy. 
2.3.13 Cell toxicity 
Trypsinised cells were collected and washed with PBS. After adding equal amounts of trypan 
blue (0.5% w/v in 0.9% NaCl) to the cell suspensions, cells were immediately counted in a 
Neubauer’s chamber and simultaneously compared with the number of live cells expressing 
eGFP using fluorescent microscopy. 
2.4 Biochemical methods 
2.4.1 Harvesting of supernatants from 293 EBNA cells 
Transfected and selected 293 EBNA cells were expanded in standard growth medium 
supplemented with 50 µg/ml β-aminopropionitrile to avoid crosslinking of expressed collagens. 
On reaching confluency the FBS was reduced to 2%. Cell culture supernatants were harvested 
every day and fresh media supplemented with fresh ascorbate and β-aminopropionitrile were 
added. 
2.4.2 Isolation and purification of collagens from the supernatants 
Immobilized-metal affinity chromatography (IMAC) was used for purification of recombinantly 
secreted collagens with N-terminal his-tags. Supernatants were thawed and the protease 
inhibitors PMSF (0.5 mM) and NEM (0.5 mM) added. Supernatants (pH adjusted to 8.0) were 
filtered through Whatman filter paper to remove suspended particles and the filtrate was loaded 
onto a column already packed with 2 ml Ni-NTA superflow matrix (Qiagen) at the rate of 1 
ml/min at 4 °C. After complete loading of the supernatants the impurities and unspecifically 
bound proteins were washed off the column with 50 ml buffer A and the bound native proteins 
eluted with buffer B. 
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Buffer A/Wash buffer  
50 mM NaH2PO4 
300 mM NaCl  
20 mM imidazole  
0.05% Tween 20 
Adjust pH to 8.0 using NaOH 
Buffer B/Elution buffer 
50 mM NaH2PO4 
300 mM NaCl  
250 mM imidazole  
Adjust pH to 8.0 using NaOH 
2.4.3 Estimation of protein concentration 
The concentration of purified collagen II variants was determined by the bicinchoninic acid 
assay (BC assay protein quantitation kit, Uptima) as per the manufacturer’s instructions. Pepsin 
extracted collagen from bovine nasal septum (Sigma) was used as an additional standard along 
with BSA. 
2.4.4 SDS polyacrylamide gel electrophoresis (SDS PAGE) 
SDS polyacrylamide gel electrophoresis was performed using the buffer system of Laemmli 
(1970). Gels were prepared using glass plates of 10 cm x 7.5 cm and spacers of 0.5 cm thickness. 
A 15 well comb was generally used for formation of the wells in the stacking gel. The 
composition of 8% resolving and 4% stacking gels is given in Table 2.8. 
Protein samples were mixed with an equal volume of 2X SDS sample buffer whereas cells were 
lysed and resuspended in 1X SDS sample buffer. Before loading, samples were reduced and 
denatured by adding 5% β-mercaptoethanol and heating at 95 ºC for 5 min. A molecular weight 
marker (NEB), run simultaneously on the same gel in an adjacent lane, was used as a standard to 
establish the apparent molecular weights of proteins resolved on SDS polyacrylamide gels. 
Table 2.8. Compostion of stacking and separating gels for SDS PAGE  
component stacking gel 4% separating gel 8% 
AA/Bis (30 %/0.8 %) 
1 M Tris pH 8.8 
1 M Tris pH 6.8 
H
2
O 
10% SDS 
10% APS 
TEMED 
4.1 ml 
- 
3.7 ml 
22.3 ml 
300 µl 
300 µl 
41 µl 
7.2 ml 
10.2 ml 
- 
9.2 ml 
300 µl 
95 µl 
24 µl 
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The molecular weight markers were prepared according to the manufacturer’s specifications. 
Pepsin extracted collagen II (Sigma) was used as an additional molecular standard marker. After 
loading the samples onto the gel, electrophoresis was performed in 1X running buffer at a 
constant voltage of 100-150 V until the bromophenol blue dye front had reached the bottom edge 
of the gel or had just run out of the gel. After electrophoresis, the resolved proteins in the gel 
were either stained with Coomassie blue, silver nitrate or transferred onto a nitrocellulose 
membrane for western blotting. 
2X SDS sample buffer 
100 mM Tris-HCl, pH 6.8 
4 % v/v SDS 
20 % v/v glycerine 
0.2 % w/v bromophenol blue 
 
10X running buffer: 
1.9 M glycine 
0.25 M Tris-HCl, pH 8.8 
1% SDS 
 
2.4.5 Coomassie blue staining of SDS-polyacrylamide gels 
The resolved proteins were visualised by staining the gel with Coomassie blue staining solution 
at room temperature with gentle agitation for at least 60 min. Then, the staining solution was 
removed and destaining solution was added. The gel was destained at room temperature with 
gentle agitation with several changes of destaining solution until protein bands were clearly 
visible. 
Coomassie blue staining solution 
0.1% w/v Coomassie blue R250  
50% v/v ethanol 
10% v/v acetic acid 
 filter the solution before use 
Destaining solution 
7% v/v acetic acid 
20% v/v ethanol 
 
2.4.6 Silver staining of gels 
Gels were carefully removed after separation of proteins and fixed by immersing in fixative 
solution for 15 min with two changes of fixative. To this 50 ml of sensitizer was added and 
incubated for 20 min. Gels were rinsed in demineralised water three times for 5 min each. 0.1 % 
silver nitrate solution was added and incubated for 15 min before the gel was quickly rinsed with 
demineralised water. 40 ml of developer was added and the reaction was stopped by adding the 
fixative solution as soon as bands appear. 
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Fixative 
250 ml methanol 
25 ml acetic acid 
to 500 ml with water 
 
 
 
 
Silver nitrate solution 
0.5 g silver nitrate 
to 500 ml with water 
80 µl of formalin  
added freshly to every 50 ml solution 
Sensitizer 
150 ml ethanol 
27.2 g sodium acetate 
1.5 ml acetic acid 
10 ml glutaraldehyde (25 %) 
0.5 g sodium thiosulfate pentahydrate 
to 500 ml with water 
 
Developer  
541 µl formalin 
10 g sodium carbonate 
to 500 ml with water 
 
2.4.7 Transfer of proteins to nitrocellulose membranes 
Proteins resolved on the gel were transferred electrophoretically to a nitrocellulose membrane in 
transfer buffer at a constant current of 100 mA overnight at 4°C. After transfer the membrane 
was stained in 10-15 ml of Ponceau S (Serva) solution for 2-5 min at room temperature to check 
the transfer of proteins. After staining, the membrane was removed from the Ponceau S solution 
and rinsed with water to destain until protein bands were visible and the background was clear. 
The positions of the constituent proteins of the molecular weight marker were marked and the 
membrane washed with TBS to completely remove the stain. 
2.4.8 Immunodetection of membrane bound proteins 
Nitrocellulose membranes with bound proteins were blocked with 5% low fat milk powder in 
TBS for 1 h. The membrane was incubated 1 to 2 h at room temperature with primary antibody 
diluted appropriately in 5% low fat milk powder in TBS followed by three washes of 5 min each 
in TBST buffer. Appropriately diluted secondary antibody coupled with horseradish peroxidase 
was added to the membrane and incubated at room temperature for one hour. Finally the 
membrane was rinsed in TBST buffer three times for 5 min each to remove unbound antibody 
and the reaction was detected using an chemiluminescence detection system. The light signals 
were captured by exposure to X-ray film (RX-Super, Fujifilm). 
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Table 2.9. List of primary and secondary antibodies used in Western blot 
Antibody Dilution Company 
Primary antibodies   
Mouse monoclonal anti-c-myc 1:1000 Santa Cruz  
Rabbit polyclonal anti-c-myc 1:1000 Santa Cruz 
Goat polyclonal anti-collagen II 1:1000 Chemicon 
Secondary antibodies   
Peroxidase conjugated anti-goat IgG 1:1000 Dako 
Peroxidase conjugated anti-rabbit IgG 1:1000 Dako 
Peroxidase conjugated anti-mouse IgG 1:1000 Dako 
 
Transfer buffer 
50 mM boric acid, pH 8.5 
10 % methanol 
ECL detection 
100 mM Tris-HCl pH 8,5  
1.25 mM luminol 
225 nM coumarin 
0.03 % hydrogen peroxide 
2.4.9 Trypsin digestion of purified collagen II proteins 
10 µl of trypsin solution (100 µg in 10 mM EDTA) was added to 50 µl of eluted protein (50 
µg/ml of protein) at pH 8.0 and incubated at 25 oC for 2 min. The reaction was stopped by 
adding 5 µl of soyabean trypsin inhibitor and 50 µl 2X SDS PAGE sample. Samples were boiled 
at 95 oC for 10 min, resolved on 8% SDS PAGE gels and subsequently the proteins detected by 
silver staining. 
2.4.10 Measurement of circular dichroism spectra and melting curves 
Purified collagen II proteins were dialyzed in 100 mM acetic acid and the concentration was 
adjusted to 60 µg/ml. 200 µl of this solution was used to measure the spectrum between 190 nm 
and 280 nm using a Jasco J-715 Polarimeter at 4 oC. Melting curves were registered  at 222 nm 
with  in a temperature range of 10 °C to 55 °C at increments of 1 °C /min. 
  Material and methods 
 
 40
2.4.11 Negative staining of collagens for electron microscopy 
Purified recombinant collagen II proteins and its variants were adsorbed to 400 mesh carbon-
coated copper grids, which had been rendered hydrophilic by glow-discharge at low pressure in 
air. The grids were immediately blotted, washed with two drops of water, and stained with 0.75 
% uranyl formate for 15 s. Samples were observed in a Jeol 1200 EX transmission electron 
microscope operated at 60 kV accelerating voltage and 300000X magnification. These 
experiments were performed at the University of Lund in cooperation with Dr. M. Mörgelin. 
2.4.12 Inhibition of proteolytic processing of collagen II using specific 
inhibitors 
Three days after transfection, HT1080 cells in six well plates were washed with medium and 
fresh medium, supplemented with 100 µg/ml of ascorbate and 50 µM proteasomal inhibitor 
MG132 (10 mM stock in DMSO) was added. Supernatants were collected 6 h, 12 h and 24 h 
respectively and resolved on an 8 % SDS-PAGE. Collagen II and fragments thereof were 
detected by western blot using an antibody directed against the myc epitope.  
GM6001 is a universal inhibitor of the MMP pathway. Three days after transfection of HT1080 
cells with collagen II constructs, supernatants were collected and the cells rinsed with fresh 
media. 25 µM GM6001 (1 mM stock in DMSO) was added to the growth medium supplemented 
with 100 µg/ml of ascorbate. Supernatants and cell lysates were harvested 48 h after addition of 
the inhibitor and resolved by SDS-PAGE on 8% gels. Collagen II and fragments thereof were 
detected by western blot using the anti-myc antibody. 
2.4.13 Mass spectrometry of purified collagen II variants 
Purified collagen II samples were reduced with 10 mM DTT at 37 oC for 2 h, alkylated with 20 
mM idodoacetamide for 1 h at 37 °C and than reduced again. MALDI-TOF spectra were 
obtained at service facility of the Centre for Molecular Medicine, University of Cologne, using a 
Reflex IV Brucker Daltonics Mass spectrometer. 
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3 Results   
3.1 Subcloning of collagen II cDNA 
Collagen II cDNA in the pBS KS+ vector was subcloned into smaller fragments and these 
fragments were used for site directed mutagenesis to introduce desired point mutations. Attempts 
to introduce specific point mutations in full length collagen II cDNA were futile due to the 
frequent introduction of unwanted mutations. Further the sequence analysis was cumbersome 
due to the high GC content. Fig 3.1 represents a schematic outline of the cloning strategy.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.1 The subcloning scheme for site directed mutagenesis of collagen II cDNA. (A) represents a 1% agarose 
gel of DNA separated after digestion of collagen II cDNA in pBS KS+ with Sac II (Lane 1). Two fragments were 
obtained, the Sac II A fragment was cloned in pBS KS+ vector and used for introducing mutations leading to R75C 
and R134C. The fragment Sac II B was ligated back at the Sac II position and further digested with Sac I. (B) shows 
fragments after digestion of Sac II B with Sac I (lane 2). The Sac I A fragment was used for introducing mutations 
leading to R704C, R740C and R789C. After introducing the desired mutation the inserts was cloned back into the 
backbone vector in the same order. M, 1 kb DNA standard marker. 
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After subcloning of the smaller fragment, the point mutations R75C and R134C were introduced 
in the Sac II A fragment and the mutations R704C, R740C and R789C in the Sac I A fragment. 
After sequence analysis to confirm the mutation of interest the respective fragments were 
digested from their vectors and cloned back into the original backbone vector to give full length 
cDNA with the desired mutation. All the cDNAs were sequenced to rule out unwanted 
mutations. 
3.2 Cloning of collagen II cDNA into pSL1180 vector 
The endogenous signal peptide in the collagen II cDNA had to be removed since the mammalian 
expression vector pCEP-Pu already contains the BM 40 signal peptide. Hence it was necessary to 
clone the collagen II cDNA constructs from the pBS KS+ vector to the pSL1180 vector. After 
mutagenesis, the collagen II cDNA was excised from the pBS KS+ vector by digestion with Spe 
I and Eco RV and then ligated into pSL1180 which was digested with the same enzymes and 
dephosphorylated (Fig 3.2). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2 Cloning of collagen II cDNA from the pBS KS+ vector into the pSL1180 vector for deletion of the 
endogenous signal peptide.A 1% agarose gel showing restriction digestion products after digestion with Spe I and 
Eco RV of collagen II cDNA in the pBS KS+ vector (lane 1) and the pSL1180 vector (lane 2). M represents the 
DNA standard marker. 
3.3 Cloning of collagen II cDNA without signal peptide into the 
mammalian expression vector pCEP-Pu 
Collagen II cDNA without endogenous signal peptide was excised from the pSL1180 vector at 
the Nhe I and Bam HI positions and ligated into the pCEP-Pu vector which had been digested 
with Nhe I and Bam HI. Fig 3.3 shows all the collagen II variants after digestion of the pCEP-Pu 
vector. 
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Fig 3.3 Restriction digestion of all collagen II constructs from pCEP-Pu.DNA was separated on a 1% agarose 
gel after restriction digestion with Nhe I and Bam HI of the collagen II cDNA cloned in the mammalian expression 
vector pCEP-Pu. M, DNA standard marker. 
3.4 Transient expression of collagen II proteins in 293 EBNA cells 
Supernatants and cell lysates from 293 EBNA cells transfected with collagen II constructs were 
reduced with mercaptoethanol and proteins separated on a 8% SDS PAGE gel (Fig 3.4). 
Recombinantly expressed collagen II was in all cases detected in the supernatants of transfected 
293 EBNA cells. Significantly higher amounts of proteins were seen in the cell lysates of R740C 
and R789C transfected cells as compared with cells expressing other collagen II variants. In 
addition, the mobility of the R789C protein was altered as compared with other collagens. 
Collagens in the cell lysates migrate slightly higher than those in the supernatants.          
                  
 
 
 
                                                                                                                                                 
 
 
Fig 3.4 Western blot analysis of supernatants and cell extracts of transfected 293 EBNA cells. 293 EBNA cells 
transiently transfected with different collagen II constructs were analysed by western blot for expression of collagen 
II proteins. Supernatants (S) and cell lysates (C) harvested three days post transfection were separated by SDS 
PAGE (8% gel) under reducing conditions and the blot was developed with an antibody directed against the myc 
epitope. NT, non transfected; WT, wild type; R75C, R134C, R134, R704C, R740C and R789C are cells transfected 
with the respective mutated collagen II variants.  
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3.5 Purification of recombinantly expressed collagen II 
To analyze the effect of these mutations by physicochemical and structural methods, proteins 
were purified from the media of 293 EBNA cells. Supernatants were harvested from 293 EBNA 
cells expressing his6-myc-tagged recombinant collagen II constructs and these were subjected to 
affinity chromatography using a nickel-NTA column. The bound protein was eluted with 
increasing imidazole concentrations (up to 250 mM). Fractions containing collagen II variants 
were separated by SDS PAGE and the gels subjected to Coomassie blue staining. Fig 3.5 shows 
respresentative gels from the purification of the wildtype and R789C constructs. 
      
 
 
 
                             
                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.5 Protein fractions from various stages of collagen purification resolved on 8% SDS PAGE gels stained 
with Coommassie blue. Panel A depicts a Coomassie stained gel of fractions from wild type collagen II and panel 
B shows the corresponding gel for R789C mutant collagen.S1, S2, cell culture supernatants; F1, flow through; W1, 
wash; E1 to E9, elution fractions 1 to 9; M, marker; SC, pepsin extracted collagen II (Sigma)  
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3.6 Coomassie staining of purified collagen II variants  
The concentrations of the purified collagen II proteins were measured and 1 µg of each variant 
was resolved on an 8% SDS PAGE gel and stained with Coomassie blue as shown in the Fig 3.6. 
Trimeric bands representing collagen II (with both the propeptides, with one propeptide and fully 
processed) as indicated by arrow marks were visible in samples of WT, R75C, R134C, R704C 
and R740C collagens. In the R789C sample a distinct single band migrating lower than all other 
variants, including the pepsin extracted collagen, was observed. 
 
 
 
 
 
 
 
 
 
Fig 3.6 Coommassie blue stained SDS-PAGE gel of all the purified collagen II variants. Triple bands as 
indicated by arrows represent the WT, R75C, R134C, R704C and R740C collagen in contrast to a single band 
migrating lower for R789C. M, protein standard; SC, pepsin extracted collagen II (Sigma).  
 
3.7 Immunoblot of purified collagen II variants 
The purified collagen II proteins were analysed by western blot using antibodies specific for 
collagen II and the N-terminal tag, respectively. With both antibodies two bands were detected, 
with the upper one being more prominent when detected with antibody directed against the myc 
epitope (Fig 3.7 A) and the lower band more intense when detected with anti-collagen II (Fig 3.7 
B). The anti-myc antibody detects the upper band which most probably corresponds to the full 
length procollagen II. Also the purified R789C migrated at a lower position than the other 
collagen II variants and the protein was intact at the N-terminal end as it could be detected with 
the anti-myc antibody.  
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Fig 3.7 Western blot analysis of all the purified collagen II variants. Purified recombinant proteins were resolved 
on 8% SDS PAGE gels and the blots developed using antibodies against collagen II (A) and the myc epitope (B), 
respectively. 
 
3.8 Trypsin digestion of different collagen II variants    
To determine the triple helical stability of different collagen II variants, these were subjected to 
trypsin digestion. A single collagen II polypeptide has 135 potential trypsin cleavage sites. In the 
case of collagen II forming stable triple helical trimers, these sites are not exposed and therefore 
not accessible to trypsin. Only the N- and C-propeptides are cleaved. Fig 3.8 shows silver stained 
gels of all collagen II variants before and after trypsin digestion. WT, R75C, R134C and R704C 
collagens were trypsin resistant, indicating that the secreted protein has formed a stable triple 
helix. R740C and R789C collagens were susceptible to trypsin digestion and completely 
degraded. This implies that the secreted R740C and R789C proteins are not forming stable triple 
helical structures.   
 
Fig 3.8 Silver stained SDS-PAGE gel after trypsin digestion of the purified collagen II variants to analyse 
their triple helical integrity. Collagen II variants were tested by digestion with trypsin at 25 °C for 2 minutes 
followed by SDS-PAGE. The collagens were visualized by silver staining. Left panel; collagen variants incubated 
without trypsin, and right panel; with trypsin. R740C and R789C collagens were extensively degraded, whereas for 
all the other constructs a single band of the size of the triple helical domain remained. 
 
A B
WT
   
R7
5C
  
R1
34C
  
R7
04C
  
R7
40C
  
R7
89C
 
WT R7
5C
R1
34C
R7
04C
R7
40C
R7
89C
-trypsin +trypsin
175
83
  Results 
 
 47
3.9 Circular dichroism of purified collagen II proteins 
The folding of triple helical collagens can be analysed by CD spectroscopy. At 222 nm a typical 
collagen spectrum shows a positive ellipticity indicating a triple helical structure. In case of a 
unstable structure, e.g. as a result of low hydroxylation, the ellipticity shifts below zero at 222 
nm. The CD spectra of the purified collagen II variants are shown in Fig 3.9. WT, R75C, R134C, 
and R704C proteins displayed normal collagen II spectra indicating a high triple helical content 
and a stable overall structure. The structure of the collagen II mutants R740C and R789C was 
clearly affected when compared to wild type collagen and the spectra indicate a decreased triple 
helical content in these proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig  3.9 CD spectra of purified collagen II variants. Spectra were recorded using collagens at a concentration of 
60 µg/ml after dialysis against 100 mM acetic acid. The structure of the mutant collagen II proteins R740C and 
R789C were altered as compared with other collagen II variants and the shape of the spectra indicate a decrease in 
triple helical structure. 
 
3.10 Melting curves of purified recombinant collagen II proteins 
Purified collagens were subjected to incremental heating with simultaneous measurement of 
molar ellipticity at 222 nm. The temperature where 50% of the triple helical structure is lost is 
defined as the melting temperature (Tm) of the respective collagen. Tm depends on the stability 
of collagen triple helix, the more stable the triple helix is the higher the Tm. The melting curves 
of all the purified collagen II proteins are shown in Fig 3.10A. The percentage of folded 
collagens as a function of temperature was determined by using a curve fit model assuming 100 
% initially folded molecules (Fig 3.10B). The curves for WT, R75C, R134C and R704C 
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collagens show similar profiles while R740C and R789C proteins showed a thermal instability as 
compared to the other collagens. The Tm values are summarized in Table 3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.10 Melting curves of purified collagen II variants. (A)  CD melting curves of collagen II proteins (60 
µg/ml) recorded after dialysis into 100 mM acetic acid at 222 nm with a 1 °C/min temperature gradient from 10 to 
55 °C. (B) The percentage folding using a curve fit model assuming that initially 100 % of the collagen molecules 
were folded. The R740C and R789C proteins displayed a decreased thermal stability when compared to all other 
collagen II variants.  
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Table 3.1 Melting points (Tm) of the purified collagen II variants 
sample melting point (Tm) 
WT 38.6 °C 
R75C 36.2 °C 
R134C 36.1 °C 
R704C 36.1 °C 
R740C 30.2 °C 
R789C 31.5 °C 
 
3.11 Mass spectrometric analysis of purified collagen II proteins 
Purified collagen II proteins were analysed by mass spectrometry to determine the masses of the 
intact protein. Fig 3.11 shows the combined mass spectra for the wildtype, R789C and pepsin 
extracted collagens (SC). Wild type collagen showed a mass of approximately 150.6 kD. This 
value was also obtained for R75C, R134C, R704C and R740C proteins (data not shown). In case 
of R789C collagen the mass of the processed protein was around 92.9 kD (Fig 3.11), lower than 
the mass obtained for pepsin extracted collagen which lacks propeptides (123.9 kD). Table 3.2 
compares the theoretical with the measured mass for all the collagen II variants.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.11 MALDI-TOF spectra of purified collagen II proteins. Wild type collagen II protein (black) gave a 
measured mass of 150.6 kD which includes the mass of the his6 myc tag. The mass of the R789C protein (red) was 
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approximately 92.9 kD. Pepsin extracted collagen from the bovine nasal cartilage, which lacks both propeptides, 
displayed a mass of 123.9 kD (green).  
 
Table 3.2 Comparison of theoretical and measured mass of collagen II variants 
sample mass from MALDI-TOF theoretical mass* 
WT 150.6 kD 136.8 kD 
R789C 92.9 kD 136.8 kD 
SCa  123.9 kD 96 kD 
             *Theoretical mass include the propeptides and tag; a pepsin extracted collagen (Sigma) 
3.12 Negative electron microscopy of purified collagen II proteins 
Purified collagen II proteins were analysed by electron microscopy after negative staining. Fig 
3.12 shows representative electron micrographs of WT, R75C R740C and R789C collagens. 
Characteristic filaments were observed in the WT and R75C samples. R134C and R704C 
collagens displayed similar structures (data not shown). In the R740C and R789C samples the 
characteristic filaments were not seen and the short proteins detected were significantly thinner 
and more sparse. In addition, R75C collagen showed kinks (arrow mark) close to the end of the 
structure. Because of the low contrast in the electron micrographs, selected filaments were 
highlighted to illustrate representative structures. 
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Fig 3.12 Electron micrographs of purified and negatively stained collagen II variants. In the wildtype and 
R75C samples characteristic collagen filaments are seen (redrawn for WT-R and R75C-R). In the R740C-R and 
R789C-R panels these filaments, if at all present, all are thinner and hardly detectable. In R75C collagen kinks were 
consistently seen (arrows). 
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3.13 HT 1080 cells transiently transfected with collagen II constructs 
HT 1080 is a fibroblast derived cell line and was used to study the intracellular trafficking of 
wild type and mutant collagen II. Three days after transfection with collagen II constructs, 
supernatants and cell lysates were analysed. Fig 3.13 shows a western blot developed with 
antibodies directed against the myc epitope. Collagen II was detected exclusively in the 
supernatants of WT, R75C, R134C and R704C cultures. In the R740C culture, protein was found 
in cell lysate and in about equal amounts in the supernatant. In the case of the R789C mutation, 
the protein was almost exclusively detected in the cell lysate indicating significant intracellular 
retention. The R789C collagen mobility was shifted as compared to other collagen II proteins in 
a manner similar to that seen with protein from 293 EBNA cells. 
 
 
 
 
 
 
 
 
 
 
Fig 3.13 Western blot analysis of collagen II variants expressed in HT1080 cells. Supernatants (S) and cell 
lysates (C) from HT1080 cells were analysed three days post transfection with antibodies directed against the myc 
epitope. Significant amounts of R740C and R789C protein were detected in the cell lysates and only a minor portion 
was secreted into the supernatants. 
3.14 Effect of the MMP inhibitor GM6001 on HT1080 cells expressing 
collagen II 
The extracellular degradation of the fibrillar collagens type I, II, and III can occur both at 
nonhelical sites (Liu et al. 1995) and through a triple helix cleavage. This is achieved by 
collagenases, which belong to the family of zinc-dependent endopeptidases called matrix 
metalloproteinases (MMPs). Collagenase-1 or MMP-1 (interstitial collagenase), collagenase-2 or 
MMP-8 (neutrophil collagenase), and the more recently cloned and characterized collagenase-3 
or MMP-13 (Freije et al. 1994 and Knauper et al. 1996) are the only mammalian enzymes known 
to be able to initiate the intrahelical cleavage of triple helical collagen at neutral pH. These three 
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collagenases have the ability to cleave the fibrillar collagens type I, II, and III at a single site 
(Gly 775–Leu/Ile 776) within each chain of the triple helical collagen molecule. 
To investigate if the shift in R789C protein mobility is due to MMP cleavage, GM6001, an 
universal inhibitor for MMPs, was used. Cells expressing wildtype and R789C collagen were 
incubated for two days with the inhibitor. Supernatants and cell lysates from these cells were 
analysed by western blot and detected with an antibody directed against myc epitope (Fig 3.14). 
In the presence of GM6001 significant amounts of R789C proteins remained uncleaved, in 
contrast to what was seen in the absence of the inhibitor. This indicates that the mutation R789C 
is aiding MMPs to cleave collagen II and thereby causes the shift in the mobility when compared 
with wild type protein. In the presence of GM6001, R789C protein can also be detected in the 
supernatant showing that inhibition of cleavage results in increased secretion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.14 Analysis of proteolytic processing in the absence (left) or presence (right) of the general MMP 
inhibitor GM6001 by western blot. Non transfected cells (NT) and cells expressing wildtype (WT) and R789C 
collagens were treated for two days with GM6001 (25µM). Supernatants (s) and cell lysates (c) were harvested and 
analysed by western blot. After treatment with GM6001 the R789C collagen was partially protected from 
degradation, indicating that the reduced mass or shift in mobility is due to a proteolytic cleavage by MMPs. 
3.15 Effect of proteasome inhibitor MG132 on processing of R789C 
Endoplasmic reticulum (ER)-associated protein degradation (ERAD) eliminates misfolded or 
unassembled proteins from the ER. ERAD targets are selected by a quality control system within 
the ER lumen and are ultimately degraded by the cytoplasmic ubiquitin-proteasome system 
(UPS) (Meusser et al 2005). 
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MG132 is a universal inhibitor used to block the proteasomal degradation pathway. To 
determine if the cleavage collagen occurs at proteasomes. HT1080 cells expressing wildtype and 
R789C collagens were treated with MG132 for 6 h, 12 h and 24 h. Supernatants from these cells 
were analysed by western blotting and collagens were detected with an antibody directed against 
the myc epitope (Fig 3.15). Treatment with MG132 did not affect the mobility of R789C 
collagen when compared with non treated R789C samples. This indicates that the cleavage of the 
R789C mutant does not involve proteasomes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.15 Effect of the proteasomal inhibitor MG132 on R789C protein expression. Supernatants  from cells 
treated for 6 h, 12 h and 24 h with MG132 (50 µM) were analysed with an anti-myc antibody. Lane 1, non 
transfected (NT); lane 2, wildtype collagen II (WT) and lane 3, mutant collagen R789C (R789C). MG132 did not 
show any affect on the collagen II processing in HT1080 cells when compared to untreated control cells (-MG132). 
3.17 ER stress response in collagen expressing HT1080 cells  
XBP-1 is a chaperone involved in the endoplasmic reticulum stress response occurring when 
misfolded proteins are retained in the ER and is used as a marker for this response. It has been 
shown previously that XBP-1 is specifically spliced as a consequence of ER stress. Therefore 
RNA of transfected HT1080 cells was isolated and XBP-1 splicing was investigated by RT-PCR 
using specific primers giving rise to a 248 bp band in the case of unspliced XBP-1 and to a 222 
bp band where XBP-1 is spliced. Fig 3.17 shows the PCR products for XBP-1. In non-
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transfected cells as well as cells transfected with wildtype, R75C, R134C and R704C constructs 
only the unspliced form of XBP-1 was detected whereas in cells transfected with R740C and 
R789C the spliced variant (XBP-S) was also present. This indicates that ER stress response is 
activated in these cells due to the mutation. 
 
 
Fig 3.16 Analysis of stress induced XBP-1 splicing by RT-PCR. mRNA isolated from HT1080 cells was used for 
RT-PCR with primers specific for XBP-1. The PCR product was analysed by agarose gel electrophoresis on 2.5 % 
gels. XBP-1 mRNA could be detected in all cells. Frame switch splicing of XBP-1 (XBP-S) due to ER stress was 
detected in cells transfected with R740C and R789C constructs. 
 
3.18 Immunofluorescence and light microscopy of HT1080 cells 
expressing collagen II variants  
The morphology of transfected HT1080 cells was visualized by light microscopy (Fig 3.17). To 
analyze the intracellular localization of the transfected collagen II variants in HT1080 cells, 
immunofluorescence staining was performed. In addition to the staining for the myc tag, a 
costaining was performed using antibodies directed against compartment specific proteins, e.g 
58K for the Golgi apparatus and PDI for the endoplasmic reticulum (ER). Using these antibodies 
the trafficking of collagen from endoplasmic reticulum to the Golgi apparatus can be followed 
and a potential retention or secretion defect revealed.  
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Fig 3.17 Phase contrast images of HT1080 cells after transfection with indicated collagen II constructs. Cells 
transfected with R740C and R789C constructs were significantly more rounded and spindle shaped as compared 
with other cells. 
 
The non-transfected cells do not show any expression of collagen II, but show the characteristic 
halfmoon shaped perinuclear staining of the Golgi compartment. In cells transfected with wild 
type, R75C, R134C and R704C constructs, expression of collagen II (green) was observed and 
this was significantly colocalised with the signal for the Golgi apparatus, indicating that most of 
the protein has reached this compartment and is in transit for secretion. In  cells transfected with  
the constructs R740C and R789C significant amounts of protein were detected in other 
intracellular compartments leading to a separate green and red signal (Fig 3.18). Less protein was 
seen colocalised with the Golgi marker, further the morphology of cells expressing R740C and 
R789C collagens was severely changed.  
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Fig 3.18 Costaining of HT1080 cells with antibodies against collagen II and the 58K Golgi marker. HT1080 
cells transfected with collagen II constructs were analysed three days post transfection with antibodies directed 
against the Golgi apparatus (red) and collagen II (green). Nuclei (blue) were counterstained with bisbenzimide. 
Colocalisation of collagen with 58K in the Golgi compartment is seen in cells transfected with WT, R75C, R134C 
and R704C constructs. In cells expressing R740C and R789C collagens significant amounts of protein are detected 
outside the Golgi apparatus.  
  
In addition, transfected HT1080 cells were analysed by immunofluorescence using an antibody 
directed against protein disulfide isomerase (PDI), an ER specific enzyme. In non-transfected 
HT1080 cells, the ER was distributed all over the cells. Fig 3.19 shows that WT, R75C, R134C, 
R704C collagen expressing cells display a clear difference between the two stainings and little 
colocalisation between the ER marker and collagen II proteins was seen. In contrast, in R740C 
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and R789C expressing cells a significant colocalisation of the ER marker and collagen II was 
observed, whereas a characteristic staining of the Golgi apparatus did not appear. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                        
 
 
 
 
 
 
 
 
 
Fig 3.19 Analysis of transfected HT1080 cells by costaining for PDI and collagen II. Three days after 
transfection with collagen II variants, HT1080 cells were analysed by immunofluorescence staining using antibodies 
directed against collagen II (green) and PDI (red). Nuclei were counterstained with bisbenzimide (blue). Non-
transfected cells show staining for PDI distributed across the cells. Cells transfected with WT, R75C, R134C, and 
R704C constructs displayed separate distinct staining for the ER and the expressed collagens with much less 
colocalisation. Significant colocalisation of PDI with collagen II staining was seen only in cells expressing R740C 
and R789C and these cells were also rounded in appearance.    
 
 
NT WT
R75C R134C 
R740C R704C 
R789C R789C 
  Results 
 
 59
NT WT 
R75C R134C 
R740C R704C 
R789C R789C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.20 Analysis of BiP expression by immunofluorescence microscopy of transfected HT1080 cells. HT1080 
cells transfected with collagen II constructs were analysed three days post transfection by staining with antibodies 
directed against collagen (red) and BiP (green). Nuclei were counterstained with bisbenzimide (blue). BiP 
expression was observed in all the cells. Collagen II (red) expression was detected in cells transfected with WT, 
R75C, R134C, and R704C constructs and there was no colocalisation with BiP. Colocalisation of BiP and collagen 
II was seen only in cells expressing R740C and R789C collagens and these cells were also rounded.    
 
An accumulation of misfolded proteins in the ER leads to an induction of stress response related 
chaperones which attempt to refold the affected proteins. One example is BiP (Sitia and 
Braakman, 2003) which is an ER resident protein. 
To determine if the intracellular protein accumulation is initiating an ER stress response in 
collagen II transfected HT1080 cells, these were analyzed by immunofluorescence microscopy 
with antibodies directed against BiP (Fig 3.20). BiP expression was observed in all the cells 
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(green fluorescence) and collagen II expression was seen around the Golgi compartment (red). In 
cells expressing R740C and R789C collagens colocalisation of BiP and collagen II proteins was 
significant and the intensity of BiP staining was also increased. Further, the cell morphology was 
rounded. 
The rounding and detachment of the cells might be a sign of cell death. Accumulation of large 
amounts of misfolded proteins might interfere with cell viability. It was investigated if these 
transfected HT1080 cells were destined to apoptosis mediated by an ER stress response due   
intracellular retention of misfolded proteins. For this purpose an FITC conjugated antibody 
directed against active caspase-3 was used for staining of HT1080 cells. Caspase-3 belongs to the 
caspase family of cysteine proteases (Martin and Green, 1995), which exist as latent zymogens 
or procaspases. Apoptosis is a form of cell death that involves the concerted action of a number 
of intracellular signaling pathways including members of the caspase family.  Oligomerization of 
procaspases is an important step leading to caspase activation, which in turn is amplified by the 
cleavage and activation of other downstream caspases (Earnshaw et al 1999 and Salvesen and 
Dixit, 1997). Activated caspase-8 and -9 activate executioner caspases, including caspase-3. 
Once active, executioner caspases cleave a number of cellular proteins, e.g. nuclear proteins, 
structural proteins, signaling molecules and cytoskeletal proteins (Stroh and Schulze 1998). 
Proteolysis of these proteins disrupts cellular homeostasis and terminates survival signals. 
To analyse if R740C and R789C transfected HT1080 cells were positive for activated caspase-3, 
these along with cells expressing other collagen II variants and non transfected cells, were 
stained for active caspase-3 three days after transfection by using an  FITC conjugated rabbit 
anti-active caspase-3 antibody (Fig 3.21). Active caspase-3 was not detected in non-transfected 
cells or the cells transfected with WT, R75C, R134C and R704C constructs, but significant 
expression was seen in R740C and R789C transfected cells. Since the active form of caspase-3 
was present in cells expressing R740C and R789C collagens, these cells are undergoing 
apoptosis, presumably due to the irreversible accumulation of misfolded proteins in the ER 
which leads to the activation of the ER stress response and, finally, to cell death. 
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Fig 3.21 Immunofluorescence staining of transfected HT1080 cells using antibodies directed against active 
caspase 3. HT1080 cells transfected with collagen II constructs were analysed three days post transfection for the 
presence of active caspase-3 (green), a marker for apoptosis. No active caspase-3 was detected in non-transfected 
cells nor in cells transfected with WT, R75C, R134C, and R704C constructs, whereas active caspase-3 was present 
in cells expressing R740C and R789C collagens.    
 
3.19 Detection of DNA cleaved due to apoptosis by nick labelling  
Caspase activation is accompanied by nuclear fragmentation, another hallmark of apoptosis. 
Hence, it was necessary to analyze if DNA fragmentation occurs in the R740C and R789C 
collagen expressing HT1080 cells. Non transfected cells and cells transfected with collagen II 
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NT WT 
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R740C R704C 
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variants were labeled for nicked DNA four days after transfection (Fig 3.22). Nick labeled DNA 
was observed in cells expressing R740C and R789C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.22 Nick labeling of HT1080 cells transfected with collagen II constructs to detect cleaved DNA. Four 
days after transfection with collagen II constructs, HT1080 cells transfected with R740C and R789C constructs 
showed distinct nick labeling (green). Nick labeling was not seen in non-transfected cells nor in cells transfected 
with constructs carrying other mutations. 
 
3.20 Single cell gel electrophoresis (comet assay) of HT1080 cells 
transfected with collagen II variants 
To ascertain whether activation of caspase-3 and nick labeling of DNA in cells transfected with 
R740C and R789C constructs leads to DNA fragmentation, HT1080 cells were analysed by 
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single cell gel electrophoresis four days post transfection. (Fig 3.23).  DNA tailing leading to a 
comet shaped appearance was observed in cells transfected with R740C and R789C constructs 
(Fig 3.23A). Further, the mean tail length was evaluated for these comets (20 cells from each 
group) using the CometScore software (Fig 3.23B). Significant increase in tail length, 
corresponding to DNA fragmentation and apoptosis was observed in cells expressing R740C and 
R789C collagens. 
                        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.23 Single cell gel electrophoresis of HT1080 cells transfected with collagen II variants. Panel A shows 
representative pictures of wild type and R789C collagen transfected cells after comet assay. In panel B the mean tail 
lengths of the comets are shown. A significant increase in tail length was observed in cells expressing R740C and 
R789C collagens whereas cells transfected with WT, R75C, R134C, R704C constructs were similar to non-
transfected controls. 
 
3.21 Comparison of the efficiency and toxicity of first and third 
generation adenoviral vectors 
Chondrocytes, the cells expressing collagen II in vivo, show a very low transfection efficiency 
when conventional methods are employed. Adenovirus based gene delivery yields a higher 
efficiency of gene transfer. Currently, two generations of adenoviral vectors are commonly used 
for transduction. First generation viruses are easier to produce and handle but only short DNAs 
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can be inserted. Further, those viruses show immunogenic potential and are toxic in animal 
models. Third generation viruses are cumbersome to produce and need a helper virus for 
packaging. However, this type of virus is non-immunogenic and less toxic in animal models and 
can accept 30-32kb foreign DNA as insert. 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.24 Transduction of primary chondrocytes using first and third generation adenoviral vectors. 
Chondrocytes were transduced with first (I) and third generation (III) adenoviral vectors expressing enhanced green 
fluorescent protein (eGFP) to determine efficiency of transduction and toxicity. A, fluorescent and phase contrast 
(PHC) images of chondrocytes three days after transduction with 100 MOI. B, viable cells expressing eGFP after 
transduction with 20, 50, 100 and 1000 MOI (moieties of infection). At 1000 MOI only few cells are viable and 
these were positive for eGFP. 
 
eGFP expressing first generation and third generation adenoviruses were used for transduction of 
chondrocytes. The proportion of cells positive for eGFP expression was higher after transduction 
with first generation vectors as compared with third generation vectors (Fig 3.24A). Similarly the 
percentage of viable cells expressing eGFP was higher in chondrocytes transducted with first 
generation adenoviruses as compared to third generation vectors (Fig 3.24B). 
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4 Discussion 
Point mutations in fibrillar collagens cause a number of abnormalities in connective tissues that 
manifest, as for example, brittle bone disease, osteoarthritis and osteochondrodysplasias. Earlier 
studies on collagen I mutations have revealed that the effects of these are remarkably dependent 
on their positions within the triple helix and that mutations localized at the N-terminus of 
collagens are less destabilizing than those occurring at the C-terminus (Byers & Cole 2002). In 
the present study, collagen II mutations leading to substitution of arginine to cysteine with 
different patient phenotypes (R75C, R789C (spondyloepiphyseal dysplasia congenital), R704C 
(Stickler syndrome)), as well as artificial mutations (R134C and R740C) were selected to 
understand the impact of the amino acid position within the Gly-X-Y repeats and the location 
either at the N- or the C-terminus of the triple helix. 
4.1 Effect of point mutations on protein expression and secretion 
Wild type and mutant collagen II proteins were expressed by transfection of 293 EBNA cells. 
Secretion of collagen II proteins into the cell culture media was detected for wild type, R75C, 
R134C and R704C expressing cells. The R740C protein was detected in equal amounts in both 
the cell lysate and supernatant, whereas R789C protein was detected almost exclusively in the 
cell lysate (Fig 3.4). Additionally, the R789C protein migrated lower on SDS gels in comparison 
to other collagen II variants. All recombinant collagen II variants could be detected with 
antibodies directed against the myc epitope as well as with collagen II antibodies, demonstrating 
that the proteins have an intact N-terminus. A shift in the SDS PAGE migration of R789C 
protein was observed for the first time and is in contrast to earlier reports (Steplewski et al. 
2004). In these studies identical mutations (R75C and R789C) were introduced into 
recombinantly engineered collagen II cDNA (Steplewski et al. 2004, Arnold et al. 1997, 1998, 
Majsterek et al. 2003), but no differences in the migration behaviour in comparison to the wild 
type collagen II were observed. In addition, the occurrence of high molecular mass aggregates, 
due to the presence of newly formed disulfide bridges were described. There is no unpaired 
cysteine present in the triple helical domain of the wild type protein and a cysteine substitution 
might therefore lead to abnormal intra- and intermolecular disulfide bridges. In the present study, 
some high molecular aggregates were detected in case of the R75C protein (data not shown) but 
not with the other collagen II variants. Altered secretion and moderate intracellular retention of 
R789C collagen was also reported for transfected HT1080 and SW-1353 cells (Steplewski et al. 
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2004, Ito et al. 2005), whereas significant intracellular retention and very low rate of secretion 
was observed for HT1080 cells expressing R789C protein. 
Analysis of pepsin extracted R789C protein expressed in rat chondrosarcoma cells showed no 
shift in the migration pattern upon SDS PAGE and no disulfide linked oligomers were detected 
(Gaiser et al. 2002). The impression that R789C is not degraded might have been due to the 
extraction procedure used. Pepsin digestion probably degraded all the mutant chains yielding 
only trimeric collagen II formed from endogenous wild type collagen II that is pepsin resistant. 
The faster migration of R789C might either be due to a difference in the protein structure and 
folding or to enhanced proteolytic processing of the protein caused by the mutation. Using 
MALDI TOF mass spectroscopy (Table 3.1), a mass of 92.9 kD was determined for the R789C 
protein, whereas wild type collagen II and all other variants had a mass of around 150.6 kD. This 
mass was significantly higher than the theoretical mass, calculated to be 136.8 kD. This higher 
mass is most probably due to posttranslational modification (glycosylation, hydroxylation) of 
collagen II during biosynthesis. The extent of collagen II modification could be estimated from 
the mass determination of pepsin extracted collagen from bovine nasal cartilage. Even in the 
absence of N- and C-propeptides, which also carry posttranslational modifications, the difference 
between measured and calculated mass was around 30 kD. 
It has been reported that hydroxylation and glycosylation varies markedly between collagen 
types and even within the same collagen type between tissues and species. In a given tissue the 
posttranslational modification depends on physiological and pathological states (Kivirikko & 
Myllyla 1979, Kivirikko 1995). The extent of these modifications plays a major role in collagen 
fibril formation and stability (Notbohm et al. 1999, Bann & Bachinger 2000, Dominguez at al. 
2005). The hydroxylation and glycosylation of recombinantly expressed collagens by various 
cell culture systems is reviewed by Bulleid et al. (2000). From the results presented here, it might 
be speculated that the reduced mass for the R789C is due to proteolytic processing of the protein 
that results in the observed shift in SDS PAGE migration. 
In addition to 293 EBNA cells, collagens were expressed in HT1080 cells, a fibroblastic cell line 
commonly used to study collagen synthesis (Fertala et al. 1994, Steplewski et al. 2005). Again, 
when expression was analyzed by SDS PAGE, wild type, R75C, R134C and R704C proteins 
were mainly detected in the supernatants. As in 293 EBNA cells the R740C protein was found in 
about equal proportions in supernatants and cell lysates. The R789C protein was exclusively 
found in the cell lysate and again migrated faster on SDS PAGE (Fig 3.13). This demonstrates a 
processing of the R789C protein irrespective of the cell line used for expression. 
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The mass spectrometry results strengthen the assumption that the protein is truncated. From the 
detection of the myc epitope in immunoblot it can be concluded that the R789C protein has an 
intact N-terminus. Therefore, the truncation of the R789C protein must occur at the C-terminal 
end of the collagen triple helix. The cleavage might be due to an increased accessibility of 
proteases to regions around the site of mutation. It is known that the degradation of fibrillar 
collagen types I, II, and III can occur in non-helical regions as well as through a triple helix 
cleavage (Liu et al. 1995) resulting in unfolding at physiological temperatures. The collagenases 
involved in these processes belong to the family of zinc-dependent endopeptidases called matrix 
metalloproteinases (MMPs). Collagenase-1 or MMP-1 (interstitial collagenase), collagenase-2 or 
MMP-8 (neutrophil collagenase), and the collagenase-3 or MMP-13 (Freije at al. 1994, Knauper 
et al. 1996) are the only mammalian enzymes so far identified which are able to initiate the 
intrahelical cleavage of triple helical collagen at neutral pH. These three collagenases cleave the 
fibrillar collagens type I, II, and III at a single site (Gly775–Leu/Ile776) within each α chain of the 
triple helical collagen molecule (Miller et al. 1976, Mitchell et al. 1996, Billinghurst et al. 1997) 
(Fig 4.1).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.1 Sequence around the potential collagenase cleavage sites in the triple helical domain of human 
collagen II. The position of arginine 789 is marked in red. (modified from Billinghurst et al. 1997).  
 
To investigate the involvement of MMPs in intrahelical cleavage of the R789C protein, 
GM6001, a universal inhibitor of MMPs which can block both intracellular and extracellular 
action of MMPs, was used on R789C expressing cells. The cleavage of the R789C protein was 
partially inhibited by pretreatment of the cells with GM6001 (Fig 3.14). Interestingly, the 
inhibition of cleavage leads to an increased secretion of the now fully intact protein into the 
supernatant. Inhibition of MMP cleavage of collagen by GM6001 was also reported earlier 
(Song & Windsor 2005, Naqvi et al. 2005). Billinghurst et al. (1997) demonstrated the presence 
of two potential collagenase cleavage sites at the amino acid position 775 and 777 in the triple 
Collagen II  
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helical domain of collagen II (Fig 4.1). The exact cleavage position in the R789C protein is yet 
to be identified, but could potentially be determined by N-terminal sequencing of the smaller C-
terminal fragment. Another possibility was the use of a neoepitope antibody directed against the 
C-terminus of the so-called COL2-3/4C fragment (Fig 4.1). This antibody would specifically 
detect the fragment if it is cleaved at the position 775. Unfortunately, no specific signal was 
detected by immunoblotting using this antibody (data not shown). This might indicate that after 
initial cleavage by MMPs, the R789C protein has undergone further cleavage, leading to the loss 
of the recognition site. Another possible explanation is that the mutation in immediate vicinity of 
the cleavage and recognition site alters the three dimensional structure so that the antibody does 
not detect the neoepitope even if generated. 
The fact that the truncated R789C protein was detected in the cell lysate demonstrates that the 
cleavage takes place already inside the cells. This implies that MMPs are active within the 
cellular compartments where the protein is retained. The fact the R789C protein is secreted when 
not cleaved is in good agreement with earlier studies (Majsterek et al. 2003, Steplewski et al. 
2004) where mutation of the MMP cleavage site gave increased secretion of R789C collagen 
(Arnold et al. 1997, Majsterek et al. 2003, Steplewski et al. 2004). 
Since the mutation R789C is in close vicinity of the MMPs cleavage sites it can be speculated 
that the mutations increases the accessibility to MMPs and thus may cause truncation of the 
R789C protein. Analysis of patients with some forms of osteoarthritis and as well as transgenic 
mice with osteoarthritis have indeed shown collagen II cleavage at this position by MMPs (Wu 
et al. 2002, Salminen et al. 2002, Tchetina et al. 2005, Xu et al. 2005). 
Treatment of HT1080 cells expressing recombinant R789C with a universal proteasome 
inhibitor, MG132, did not affect the mobility of R789C (Fig 3.15), indicating that the mutant 
protein is not cleaved by endoplasmic reticulum associated protein degradation (ERAD) using 
the cytoplasmic ubiquitin-proteasome system (Meusser et al. 2005). 
4.2 Impact of arginine to cysteine mutations on the structure and 
stability of collagen II 
To check the stability of recombinantly expressed collagen II and mutants containing arginine to 
cysteine mutations, proteins were analysed by protease digestion, CD spectroscopy and electron 
microscopy. Wild type, R75C, R134C and R704C proteins were protease resistant on treatment 
with trypsin at 25 °C as evidenced by a protease-resistant band corresponding to the collagenous 
domain (Fig 3.8). Similar treatment on R740C and R789C collagens lead to complete 
degradation indicating an unfolding of the triple helix. Such an instability was reported for 
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patient mutations in COL3A1 causing Ehlers-Danlos syndrome type IV (Narcisi et al. 1993), in 
COL1A2 mutations leading to type I osteogenesis imperfecta (Zhuang et al. 1993) and in 
collagens recombinantly expressed in vitro (Bruckner & Prockop 1981, Raghunath et al. 1994, 
Olague-Marchen et al. 2000, Galicka et al. 2003, Cabral at al. 2001). In contrast to the results 
presented here, other groups have shown that the R789C protein was resistant to digestion with 
trypsin and chymotrypsin (Steplewski et al. 2004). However, this trypsin resistance was observed 
only when the MMP cleavage site was mutated and intact full length R789C protein was 
secreted. As mentioned above, the presumed MMP processing reduces stability and increases the 
susceptibility for further degradation. 
The impact of R740C and R789C on the stability and integrity of the triple helix was further 
confirmed by CD spectroscopy and by determination of melting temperatures (Tm). Wild type, 
R75C, R134C and R704C proteins displayed typical collagen CD spectra (Fig 3.9).  In contrast, 
a shift of the spectrum to below zero at 222 nm for R740C and R789C proteins indicates that 
there is a decrease in triple helical structures in these mutants. Similarly glycine substitutions 
lead to destabilization in collagen XVII (Tasanen et al. 2000). The melting temperature of wild 
type collagen II was 38.6 °C, 2.4 °C lower than for collagen extracted from bovine nasal 
cartilage (Liang & Chakrabarti 1981, Amudeswari et al. 1987, Arnold et al. 1998). This 
difference in absolute melting temperature might be caused by inefficient hydroxylation by 293 
EBNA cells (Wagner et al. 2000; Mizuno et al. 2003). The R75C, R134C and R704C proteins 
had a 2.5 °C lower melting temperature than the wild type protein and the Tm values of the 
R789C and R740C proteins were further decreased to 31.5 °C and 30.2 °C, respectively. The 
decreased Tm of the R789C protein is in agreement with earlier studies (Steplewski et al. 2004), 
although in the present study the Tm of the truncated protein was determined whereas others 
have analyzed the full length form. 
The thermal instability is caused by unstable triple helical structures. An increased monomer 
content and lowered trimer population has been shown to result in dramatic decrease in triple 
helix content, melting temperature and, in turn, stability when using collagen like model peptides 
with glycine to alanine exchanges (Bhate et al. 2002). When using an algorithm to predict the 
structure and stability of collagen triple helices from amino acid sequences (Persikov et al. 2005) 
the R789C protein depicted a significant difference in the stability around the amino acid 
sequence 783 to 795. The other mutants studied did not show such pronounced local 
destabilization (Fig 4.2).  
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Fig 4.2 Calculated relative stability profiles in the immediate vicinity of arginine to cysteine mutations in the 
collagen II compared to the wild type protein. (http://semimajor.net/collagen_calculator/). 
 
The structural instability of the R740C and R789C proteins was confirmed by negative staining 
electron microscopy (Fig 3.12). In contrast to the wild type collagen, which showed 
characteristic procollagen structures (Lightfoot et al. 1992), the R740C and R789C samples 
contain only short filaments. This again indicates that these molecules do not form stable triple 
helices and are therefore not visible by negative staining. Other mutant proteins, such as R75C, 
R134C and R704C, showed filamentous structures comparable with wild type. However, kinks 
were consistently seen in most of the R75C filaments. The kinks were at the end of the filaments 
which agrees with where the mutation is located. Similar kinked structures were previously 
reported for collagen I molecules harboring mutations leading to osteogenesis imperfecta (Vogel 
et al. 1988, Lightfoot et al. 1992). 
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All results from biochemical studies support the conclusion that the R740C and R789C proteins 
form unstable triple helices. In addition, the local instability around the R789C mutation leads to 
increased accessibility for MMP cleavage leading to a truncated protein which is then susceptible 
for digestion by less specific proteases. 
4.3 Impact of collagen II mutations on protein trafficking  
The fibroblastic cell line HT1080 is commonly used to study the protein expression, trafficking 
and secretion of collagen II (Fertala et al. 1994, Steplewski et al. 2005). Immunoblotting 
revealed that a considerable amount of R740C and R789C protein was present in the cell lysate, 
suggesting intracellular retention.  
By immunofluorescence costaining with compartment specific antibodies, the WT, R75C, 
R134C and R704C proteins were seen to be mainly present in the Golgi compartment (Fig 3.18). 
This indicates that most of these proteins are being transported to the extracellular space. In 
contrast, R740C and R789C proteins were detected in other cellular compartments, and showed 
only weak colocalisation with the 58k Golgi marker. Moreover, colocalisation of R740C and 
R789C procollagens with PDI, a marker for the endoplasmic reticulum, was observed in these 
cells (Fig 3.19). PDI is an ER resident chaperone and functions in retaining unassembled or 
misfolded proteins within the ER. It binds to unfolded collagens preventing aggregation (John et 
al. 1993, Kivirikko & Myllyharju 1998) and acts as an ER resident quality control. This might 
suggest that the mutant R740C and R789C proteins are recognized as misfolded by the PDI 
which may be bound to these proteins, leading to colocalisation. Misfolded proteins are retained 
by the ER quality control system and subjected to either degradation or refolding (Bottomley et 
al. 2001). The intracellular retention of the misfolded R740C and R789C collagens in the ER is 
in agreement with the intracellular retention, due to point mutations, of other cartilage proteins 
such as COMP and collagen IX in patients with inherited skeletal dysplasias (Hecht et al. 2004, 
Vranka et al. 2001). Intracellular retention was also observed in mice harboring mutations in the 
collagen II C-propeptide (Fernandes et al. 2003). Intracellular retention has also been shown to 
result from point mutations in the triple helical domain of collagen II (Tiller at al. 1995). 
Interestingly, most of the retained collagens have substitutions of glycine in the Gly-X-Y repeats 
in the triple helical domain (Tiller et al. 1995, Vissing et al. 1989). Intracellular retention was 
reported to be due to abnormal disulfide bridges after the introduction of cysteine in the triple 
helix. Cysteine induced abnormal disulfide bridges were reported for COL1A1 mutations in cells 
cultured from patient skin biopsies, which also showed a dilated endoplasmic reticulum 
(Nuytinck et al. 2000). Along the same lines glycine to cysteine substitution in collagen II caused 
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reduced secretion of the protein and protein dimers were formed (Mundlos et al. 1996). 
Similarly, truncated protein due to exon deletion in the α3 chain of collagen IX caused 
intracellular retention in chondrocytes (Bonnemann et al. 2000). It appears that mutation-induced 
intracellular retention can be due to various factors, such as substitution by bulkier amino acid, 
presence of artificial disulfide bridges, misfolding as in R740C and truncation as in R789C.   
The retention of misfolded protein in the ER leads to the activation of a complex signal 
transduction pathway called the misfolded or unfolded protein response (UPR) (Rutkowski & 
Kaufman 2004, Zhang & Kaufman 2004). The UPR has evolved to limit the potential impact of 
protein accumulation on cellular homeostasis and involves the activation of transcription factor-6 
and XBP-1 (X-box DNA binding protein-1) (Lee et al. 2003, Yoshida et al. 2001). In cells 
undergoing ER stress, active XBP-1 is generated by excision of a 26 bp nucleotide sequence 
from the XBP-1 transcript by IRE1 endonuclease, one of three ER transmembrane “stress 
sensors” (Calfon et al. 2002). RT-PCR results from transfected HT1080 cells show the presence 
of XBP-1 spliced variant in addition to the unspliced form in cells expressing R740C and R789C 
(Fig 3.16). This result is in agreement with the results from Wilson et al. (2005) where misfolded 
protein accumulation due to a mutation in the NC1 domain of collagen X lead to splicing of 
XBP-1. XBP-1 splicing leads to the active up-regulation of ER-resident molecular chaperones 
like BiP and other components of the ER-associated protein degradation machinery (Yoshida et 
al. 2003, Oyadomari & Mori 2004). Upregulation and colocalisation of BiP (ER resident 
molecular chaperone) with R740C and R789C procollagen chains was observed by 
immunofluorescence (Fig 3.20). Similar results were also reported for upregulation and binding 
of BiP to collagen chains harboring mutations in type I collagen from patients with osteogenesis 
imperfecta (Chessler & Byers 1993). Splicing of XBP-1 leads to upregulation of BiP in response 
to accumulation of misfolded collagen X (Wilson et al. 2005). In case of the R740C and R789C 
collagen II mutations it appears that misfolded and truncated protein, accumulate in the ER and 
this triggers an ER stress response leading to the activation of ERAD. ER stress response also 
can downregulate protein synthesis and lead to growth arrest, PERK an ER transmembrane 
protein which plays a role in inhibition of cell cycle and PERK associated phosphorylation of 
translation elongation factor 2α (eIF2α) blocks translation (Brewer & Diehl 2000, Kaufman 
1999, Sood et al. 2000). Inhibition of proteasomes using MG132 did not affect R789C collagen 
(Fig 3.14), which indicates that this collagen is not degraded by the ERAD machinery. This leads 
to accumulation of misfolded proteins in the ER of R740C and R789C expressing cells and this 
abnormal accumulation results in an altered cellular morphology (Fig 3.17) which correlates with 
cell death. Similar flattened chondrocytes as well as a reduced cell number was reported in mice 
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harboring R789C mutation. These chondrocytes also displayed a distended endoplasmic 
reticulum (Gaiser et al. 2002).  
4.4 Fate of cells expressing R740C and R789C collagens 
Accumulation of misfolded R740C and R789C procollagens in the ER does not result in 
degradation but continuous protein accumulation may cause programmed cell death 
(Breckenridge et al. 2003, Sitia & Braakman 2003, Rao et al. 2004). Indeed, the large amount of 
rounded and dead cells observed in cultures expressing R740C and R789C collagens (Fig 3.17) 
may indicate that the cells are undergoing apoptosis. This was confirmed by the detection of 
active caspase-3 in cells transfected with R740C and R789C constructs but not in cells 
transfected with other collagen II variants. Active caspase-3 is implicated in mutations leading to 
disruption of cellular homeostasis and apoptosis (Mulugeta et al. 2005). Presence of nicked DNA 
(Fig 3.22) and increased tail length of comets (Fig 3.23) (DNA fragmentation) in cells 
expressing R740C and R789C collagens confirms that these cells are undergoing apoptosis (Fig 
4.3). This result agrees with other studies in which cell death was reported due to the 
intracellular accumulation of mutant COMP proteins (Hashimoto et al. 2003) and apoptosis in 
chondrocytes due to ER stress has been reported (Yang et al. 2005). Our results indicates that 
expression of R740C and R789C collagens leads to an ER storage disease, similar to that 
observed in pseudoachondroplasia (Dinser et al. 2002) and this may be the reason for the reduced 
number of chondrocytes observed in patients and in animal models (Hecht et al. 1998, 2005, 
Gaiser et al. 2002).  
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Fig. 4.3 Schematic representation of intracellular events occurring in the bioynthesis of R740C and R789C 
collagens. R740C and R789C mutant proteins do not form proper triple helical molecules. This leads to impaired 
trafficking and thereby accumulation in the ER lumen which in turn triggers an ER stress response leading to 
splicing of XBP-1 by IRE1. Finally as the proteins are not degraded, accumulation triggers apoptosis as seen by the 
activation of effector caspases. (modified from Baum & Brodsky 1999,  Breckenridge et al. 2003). 
 
 
XBP-
BiP 
Accumulation of 
misfolded proteins 
in the ER 
Biosynthesis & post 
translational 
modification in the ER 
Effector Caspases 
Active Caspase-3 
Apoptosis 
  Discussion 
 
 75
4.5 Consequences of intracellular retention of collagen II for the   
assembly of extracellular matrix 
The cartilage extracellular matrix is composed of intricate networks, formed by interactions 
between a large number of proteins and proteoglycans. Collagen II is the major collagenous 
component in cartilage and forms fibrils together with other collagens such as collagen IX and 
XI (Reginato & Olsen 2002) that directly or indirectly interact with noncollagenous components, 
e.g. aggrecan, fibronectin, decorin, fibromodulin, lumican, matrilins and COMP (Poole 2001, 
Mann et al. 2004). Thereby mutations in collagen II may have profound effects on the overall 
structure of the extracellular matrix.  
Intracellular retention with delayed secretion of R789C collagen  leads to abnormal binding to 
fibronectin, thereby altering the intracellular and extracellular processes in which fibronectin 
takes part (Ito et al. 2005). In addition, altered interactions of R789C collagen II  with collagen 
IX may lead to a change in the architecture of the ECM in the patients harboring these  mutations 
(Ito et al. 2005, Steplewski et al. 2005). Also using computer modeling, R789C displayed a 
decrease in electrostatic potential around the vicinity of the mutation (Steplewski at al. 2005) and 
this was correlated to the altered interaction with collagen IX. 
In some chondrodysplasias secretion of mutant COMP is markedly delayed, and collagen IX is 
partially coretained in the ER. However, collagen II secretion is not affected and collagen II can 
be detected in the matrix (Dinser et al. 2002, Hecht et al. 2005). This indicates that the secretory 
pathways for COMP and collagen II are different and that the secretion of collagen IX is more 
closely associated with that of COMP.  
Complete retention of collagen II could cause its complete absence in the matrix. This would 
represent a knockout situation as in collagen II deficient mouse models. These show highly 
disorganized chondrocytes in a cartilage which completely lacks extracellular fibrils (Liu et al. 
1995). Similar observations were also made in transgenic mice carrying a partially deleted 
human COL2A1 gene which developed a chondrodysplasia phenotype. The extracellular matrix 
in these mice contained fewer collagen fibrils and the individual fibrils were thinner 
(Vandenberg et al. 1991). Similarly, transgenic mice harboring glycine to cysteine and arginine 
to cysteine mutations in the triple helical domain developed chondrodysplasia. The chondrocytes 
displayed a distended and dilated endoplasmic reticulum and the matrix consisted of thin 
collagen fibrils (Garofalo et al. 1991, Gaiser at al. 2002). This agrees well with the results with 
R740C and R789C collagen expressed by HT1080 cells where the intracellular accumulation of 
mutant proteins leads to cell death and this may contribute to altered extracellular matrix.  
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In case of R704C collagen, the mutation might lead to haploinsufficiency of collagens fibrils in 
the matrix. Haploinsufficiency was indicated in mutations in collagen II leading to Stickler 
syndrome, where mutated mRNA was subjected to nonsense-mediated mRNA decay (Richards 
et al. 2000) and may be the molecular basis of Stickler syndrome (Freddi et al. 2000). Although 
the HT1080 cells are a frequently used model, attempts should be made to confirm the result 
with real chondrocytes, which are the natural producers of collagen II. However, repeated 
attempts to transfect chondrocytes with plasmid vectors encoding collagen II and its variants 
were unsuccessful. Hence, adenoviral vectors containing collagen II cDNA with the desired 
mutations were cloned. Adenovirus based vectors have been successfully used to study the 
effects of COMP mutations in chondrocytes (Dinser et al 2002). The efficiency and toxicity of 
first and third generation adenoviral vectors in transducing chondrocytes were evaluated by using 
eGFP expressing viruses. First generation vectors were highly efficient with decreased toxicity in 
comparison with third generation vectors when used to transducer cultured bovine chondrocytes 
(Fig 3.24). Further analysis of transduced chondrocytes will shed light on the intricate role of 
different mutations in the cartilage. 
4.6 Conclusion 
The results obtained with point mutations resulting in substitution of arginine to cysteine within 
the triple helical domain of collagen II carry the following implications: 
The R75C (Y position) and R134C (X position) mutations did not cause any biochemical 
alterations except for the presence of kinks in R75C collagen. Similar result were obtained for 
the R704C (X position) mutation. In case of R740C (X position) and R789C (Y position) the 
mutations had deleterious effects on protein structure irrespective of being in the X or Y 
position. 
Cells expressing the R75C, R134C and R704C mutations were phenotypically normal and the 
protein trafficking was not affected, whereas cell death was observed for R740C and R789C 
mutants, caused by the accumulation of misfolded proteins in the endoplasmic reticulum. 
With regard to the location, mutations at the N-terminus of the triple helix had less severe effects 
than such towards the C-terminus.  The R740C and R789C mutation located towards the C-
terminus displayed a deleterious effect on the protein structure and caused apoptosis of the 
expressing cells irrespective of being in the X or Y position. This result is in agreement with the 
finding that glycine substitutions towards the C-terminus of the collagen I chains are clinically 
more severe than those towards the N-terminus (Bateman et al. 1992) and may be due to the fact 
that mutations at the C-terminus lead to a disruptive effect during helix initiation and 
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propagation (Bonadio & Byers 1985, Byers 1990, Kuivaniemi et al 1991, Bateman et al. 1984, 
1986, 1992). However R704C, another mutation towards the C terminus, did not show any lethal 
effect. The phenotype in these patients may be due to haploinsuficiency in collagen II (Richards 
et al. 2000).  
In patients with R75C and R704C, the mutations might contribute to disease together with other 
factors such as genetic modifiers or the presence of additional mutations in other gene loci yet to 
be identified. Similar observations have been made in patients with MED (Jakkula et al. 2005).  
These results suggests that a single amino acid alteration in collagen II could lead to skeletal 
abnormalities through multiple secondary effects on the synthesis and assembly of ECM 
components. Chondrodysplasia is clearly caused not just by the formation of abnormal matrix 
molecules but also by the effect of these mutations on protein trafficking and apoptosis possibly 
augmented by environmental factors and genetic modifiers. The alteration of ECM components 
may lead to a cascade of disruption of other gene activities which collectively contribute to the 
pathological changes and thereby contribute to the phenotype in patients. 
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Appendix 
 
a. Collagen II cDNA sequence used in the present study  
The codons which are marked in red represent arginines that have been exchanged to cysteines in 
the present study.  
 
ATGATTCGCCTCGGGGCTCCCCAGTCGCTGGTGCTGCTGACGCTGCTCGTCGCCGCTGTCCTTC
GGTGTCAGGGCCAGGATGTCCGGCAACCAGGACCAAAGGGACAGAAAGGAGAACCTGGAGACAT
CAAGGATATTGTAGGACCCAAAGGACCTCCTGGGCCTCAGGGACCTGCAGGGGAACAAGGACCC
AGAGGGGATCGTGGTGACAAAGGTGAAAAAGGTGCCCCTGGACCTCGTGGCAGAGATGGAGAAC
CTGGGACCCCTGGAAATCCTGGCCCCCCTGGTCCTCCCGGCCCCCCTGGTCCCCCTGGTCTTGG
TGGAAACTTTGCTGCCCAGATGGCTGGAGGATTTGATGAAAAGGCTGGTGGCGCCCAGTTGGGA
GTAATGCAAGGACCAATGGGCCCCATGGGACCTCGAGGACCTCCAGGCCCTGCAGGTGCTCCTG
GGCCTCAAGGATTTCAAGGCAATCCTGGTGAACCTGGTGAACCTGGTGTCTCTGGTCCCATGGG
TCCCCGTGGTCCTCCTGGTCCCCCTGGAAAGCCTGGTGATGATGGTGAAGCTGGAAAACCTGGA
AAAGCTGGTGAAAGGGGTCCGCCTGGTCCTCAGGGTGCTCGTGGTTTCCCAGGAACCCCAGGCC
TTCCTGGTGTCAAAGGTCACAGAGGTTATCCAGGCCTGGACGGTGCTAAGGGAGAGGCGGGTGC
TCCTGGTGTGAAGGGTGAGAGTGGTTCCCCGGGTGAGAACGGATCTCCGGGCCCAATGGGTCCT
CGTGGCCTGCCTGGTGAAAGAGGACGGACTGGCCCTGCTGGCGCTGCGGGTGCCCGAGGCAACG
ATGGTCAGCCAGGCCCCGCAGGTCCTCCGGGTCCTGTCGGTCCTGCTGGTGGTCCTGGCTTCCC
TGGTGCTCCTGGAGCCAAGGGTGAAGCCGGCCCCACTGGTGCCCGTGGTCCTGAAGGTGCTCAA
GGTCCTCGCGGTGAACCTGGTACTCCTGGGTCCCCTGGGCCTGCTGGTGCCTCCGGTAACCCTG
GAACAGATGGAATTCCTGGAGCCAAAGGATCTGCTGGTGCTCCTGGCATTGCTGGTGCTCCTGG
CTTCCCTGGGCCACGGGGTCCTCCTGGCCCTCAAGGTGCAACTGGTCCTCTGGGCCCGAAAGGT
CAGACGGGTGAACCTGGTATTGCTGGCTTCAAAGGTGAACAAGGCCCCAAGGGAGAACCTGGCC
CTGCTGGCCCCCAGGGAGCCCCTGGACCCGCTGGTGAAGAAGGCAAGAGAGGTGCCCGTGGAGA
GCCTGGTGGCGTTGGGCCCATCGGTCCCCCTGGAGAAAGAGGTGCTCCCGGAAACCGCGGTTTC
CCAGGTCAAGATGGTCTGGCAGGTCCCAAGGGAGCCCCTGGAGAGCGAGGGCCCAGTGGTCTTG
CTGGCCCCAAGGGAGCCAACGGTGACCCTGGCCGTCCTGGAGAACCTGGCCTTCCTGGAGCCCG
GGGTCTCACTGGCCGCCCTGGTGATGCTGGTCCTCAAGGCAAAGTTGGCCCTTCTGGAGCCCCT
GGTGAAGATGGTCGTCCTGGACCTCCAGGTCCTCAGGGGGCTCGTGGGCAGCCTGGTGTCATGG
GTTTCCCTGGCCCCAAAGGTGCCAACGGTGAGCCTGGCAAAGCTGGTGAGAAGGGACTGCCTGG
TGCTCCTGGTCTGAGGGGTCTTCCTGGCAAAGATGGTGAGACAGGTGCTGCAGGACCCCCTGGC
CCTGCTGGACCTGCTGGTGAACGAGGCGAGCAGGGTGCTCCTGGGCCATCTGGGTTCCAGGGAC
TTCCTGGCCCTCCTGGTCCCCCAGGTGAAGGTGGAAAACCAGGTGACCAGGGTGTTCCCGGTGA
AGCTGGAGCCCCTGGCCTCGTGGGTCCCAGGGGTGAACGAGGTTTCCCAGGTGAACGTGGCTCT
CCCGGTGCCCAGGGCCTCCAGGGTCCCCGTGGCCTCCCCGGCACTCCTGGCACTGATGGTCCCA
AAGGTGCATCTGGCCCAGCAGGCCCCCCTGGCGCACAGGGCCCTCCAGGTCTTCAGGGAATGCC
TGGCGAGAGGGGAGCAGCTGGTATCGCTGGGCCCAAAGGCGACAGGGGTGACGTTGGTGAGAAA
GGCCCTGAGGGAGCCCCTGGAAAGGATGGTGGACGAGGCCTGACAGGTCCCATTGGCCCCCCTG
GCCCAGCTGGTGCTAACGGCGAGAAGGGAGAAGTTGGACCTCCTGGTCCTGCAGGAAGTGCTGG
TGCTCGTGGCGCTCCGGGTGAACGTGGAGAGACTGGCCCCCCCGGACCAGCGGGATTTGCTGGG
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CCTCCTGGTGCTGATGGCCAGCCTGGGGCCAAGGGTGAGCAAGGAGAGGCCGGCCAGAAAGGCG
ATGCTGGTGCCCCTGGTCCTCAGGGCCCCTCTGGAGCACCTGGGCCTCAGGGTCCTACTGGAGT
GACTGGTCCTAAAGGAGCCCGAGGTGCCCAAGGCCCCCCGGGAGCCACTGGATTCCCTGGAGCT
GCTGGCCGCGTTGGACCCCCAGGCTCCAATGGCAACCCTGGACCCCCTGGTCCCCCTGGTCCTT
CTGGAAAAGATGGTCCCAAAGGTGCTCGAGGAGACAGCGGCCCCCCTGGCCGAGCTGGTGAACC
CGGCCTCCAAGGTCCTGCTGGACCCCCTGGCGAGAAGGGAGAGCCTGGAGATGACGGTCCCTCT
GGTGCCGAAGGTCCACCAGGTCCCCAGGGTCTGGCTGGTCAGAGAGGCATCGTCGGTCTGCCTG
GGCAACGTGGTGAGAGAGGATTCCCTGGCTTGCCTGGCCCATCGGGTGAGCCCGGCAAGCAGGG
TGCTCCTGGAGCATCTGGAGACAGAGGTCCTCCTGGCCCCGTGGGTCCTCCTGGCCTGACGGGT
CCTGCAGGTGAACCCGGACGAGAGGGAAGCCCCGGTGCTGATGGCCCCCCTGGCAGAGATGGCG
CTGCTGGAGTCAAGGGTGATCGTGGTGAGACTGGTGCTGTGGGAGCTCCTGGAGCCCCTGGGCC
CCCTGGCTCCCCTGGCCCCGCTGGTCCAACTGGCAAGCAAGGAGACAGAGGAGAAGCTGGTGCA
CAAGGCCCCATGGGACCCTCAGGACCAGCTGGAGCCCGGGGAATCCAGGGTCCTCAAGGCCCCA
GAGGTGACAAAGGAGAGGCTGGAGAGCCTGGCGAGAGAGGCCTGAAGGGACACCGTGGCTTCAC
TGGTCTGCAGGGTCTGCCCGGCCCTCCTGGTCCTTCTGGAGACCAAGGTGCTTCTGGTCCTGCT
GGTCCTTCTGGCCCTAGAGGTCCTCCTGGCCCCGTCGGTCCCTCTGGCAAAGATGGTGCTAATG
GAATCCCTGGCCCCATTGGGCCTCCTGGTCCCCGTGGACGATCAGGCGAAACCGGTCCTGCTGG
TCCTCCTGGAAATCCTGGGCCCCCTGGTCCTCCAGGTCCCCCTGGCCCTGGCATCGACATGTCC
GCCTTTGCTGGCTTAGGCCCGAGAGAGAAGGGCCCCGACCCCCTGCAGTACATGCGGGCCGACC
AGGCAGCCGGTGGCCTGAGACAGCATGACGCCGAGGTGGATGCCACACTCAAGTCCCTCAACAA
CCAGATTGAGAGCATCCGCAGCCCCGAGGGCTCCCGCAAGAACCCTGCTCGCACCTGCAGAGAC
CTGAAACTCTGCCACCCTGAGTGGAAGAGTGGAGACTACTGGATTGACCCCAACCAAGGCTGCA
CCTTGGACGCCATGAAGGTTTTCTGCAACATGGAGACTGGCGAGACTTGCGTCTACCCCAATCC
AGCAAACGTTCCCAAGAAGAACTGGTGGAGCAGCAAGAGCAAGGAGAAGAAACACATCTGGTTT
GGAGAAACCATCAATGGTGGCTTCCATTTCAGCTATGGAGATGACAATCTGGCTCCCAACACTG
CCAACGTCCAGATGACCTTCCTACGCCTGCTGTCCACGGAAGGCTCCCAGAACATCACCTACCA
CTGCAAGAACAGCATTGCCTATCTGGACGAAGCAGCTGGCAACCTCAAGAAGGCCCTGCTCATC
CAGGGCTCCAATGACGTGGAGATCCGGGCAGAGGGCAATAGCAGGTTCACGTACACTGCCCTGA
AGGATGGCTGCACGAAACATACCGGTAAGTGGGGCAAGACTGTTATCGAGTACCGGTCACAGAA
GACCTCACGCCTCCCCATCATTGACATTGCACCCATGGACATAGGAGGGCCCGAGCAGGAATTC
GGTGTGGACATAGGGCCGGTCTGCTTCTTGTAAAAACCTGAACCCAGAAACAACACAATCCGTT
GCAAACCCAAAGGACCCAAGTACTTTCCAATCTCAGTCACTCTAGGACTCTGCACTGAATGGCT
GACCTGACCTGATGTCCATTCATCCCACCCTCTCACAGTTCGGACTTTTCTCCCCTCTCTTTCT
AAGAGACCTGAACTGGGCAGACTGCAAAATAAAATCTCGGTGTTCTATTTATTTATTGTCTTCC
TGTAAGACCTTCGGGTCAAGGCAGAGGCAGGAAACTAACTGGTGTGAGTCAAATGCCCCCTGAG
TGACTGCCCCCAGCCCAGGCCAGAAGACCTCCCTTCAGGTGCCGGGCGCAGGAACTGTGTGTGT
CCTACACAATGGTGCTATTCTGTGTCAAACACCTCTGTATTTTTTAAA 
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b. Collagen II protein sequence 
The protein sequence of collagen II including, BM40 signal peptide, the hexahistidine motif 
(yellow) and the my epitope is shown. Arginines which are substituted to cysteines in the present 
study are marked in red. The triple helical domain is marked by the shaded area. 
 
MRAWIFFLLCLAGRALAAPLVHHHHHHGPLVDVASNEQKLISEEDLASMTGGQQMGRDIEGRGL
AQDVRQPGPKGQKGEPGDIKDIVGPKGPPGPQGPAGEQGPRGDRGDKGEKGAPGPRGRDGEPGT
PGNPGPPGPPGPPGPPGLGGNFAAQMAGGFDEKAGGAQLGVMQGPMGPMGPRGPPGPAGAPGPQ
GFQGNPGEPGEPGVSGPMGPRGPPGPPGKPGDDGEAGKPGKAGERGPPGPQGARGFPGTPGLPG
VKGHRGYPGLDGAKGEAGAPGVKGESGSPGENGSPGPMGPRGLPGERGRTGPAGAAGARGNDGQ
PGPAGPPGPVGPAGGPGFPGAPGAKGEAGPTGARGPEGAQGPRGEPGTPGSPGPAGASGNPGTD
GIPGAKGSAGAPGIAGAPGFPGPRGPPGPQGATGPLGPKGQTGEPGIAGFKGEQGPKGEPGPAG
PQGAPGPAGEEGKRGARGEPGGVGPIGPPGERGAPGNRGFPGQDGLAGPKGAPGERGPSGLAGP
KGANGDPGRPGEPGLPGARGLTGRPGDAGPQGKVGPSGAPGEDGRPGPPGPQGARGQPGVMGFP
GPKGANGEPGKAGEKGLPGAPGLRGLPGKDGETGAAGPPGPAGPAGERGEQGAPGPSGFQGLPG
PPGPPGEGGKPGDQGVPGEAGAPGLVGPRGERGFPGERGSPGAQGLQGPRGLPGTPGTDGPKGA
SGPAGPPGAQGPPGLQGMPGERGAAGIAGPKGDRGDVGEKGPEGAPGKDGGRGLTGPIGPPGPA
GANGEKGEVGPPGPAGSAGARGAPGERGETGPPGPAGFAGPPGADGQPGAKGEQGEAGQKGDAG
APGPQGPSGAPGPQGPTGVTGPKGARGAQGPPGATGFPGAAGRVGPPGSNGNPGPPGPPGPSGK
DGPKGARGDSGPPGRAGEPGLQGPAGPPGEKGEPGDDGPSGAEGPPGPQGLAGQRGIVGLPGQR
GERGFPGLPGPSGEPGKQGAPGASGDRGPRGPPGPVGPPGLTGPAGEPGREGSPGADGPPGRDG
AAGVKGDRGETGAVGAPGAPGPPGSPGPAGPTGKQGDRGEAGAQGPMGPSGPAGARGIQGPQGP
RGDKGEAGEPGERGLKGHRGFTGLQGLPGPPGPSGDQGASGPAGPSGPRGPPGPVGPSGKDGAN
GIPGPIGPPGPRGRSGETGPAGPPGNPGPPGPPGPPGPGIDMSAFAGLGPREKGPDPLQYMRAD
QAAGGLRQHDAEVDATLKSLNNQIESIRSPEGSRKNPARTCRDLKLCHPEWKSGDYWIDPNQGC
TLDAMKVFCNMETGETCVYPNPANVPKKNWWSSKSKEKKHIWFGETINGGFHFSYGDDNLAPNT
ANVQMTFLRLLSTEGSQNITYHCKNSIAYLDEAAGNLKKALLIQGSNDVEIRAEGNSRFTYTAL
KDGCTKHTGKWGKTVIEYRSQKTSRLPIIDIAPMDIGGPEQEFGVDIGPVCFL 
 
